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transport of organelles in directionally migrating fibroblasts 
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Deacetylation of non-histone substrates by histone deacetylase 6 (HDAC6) has been 
shown to affect chemotactic invasion (e.g., Haggarty et al., 2003; Hubbert et al., 2002; Tran et 
al., 2007) or wound healing motility (Lafarga et al., 2012) of fibroblasts. Chemotactic invasion 
and wound-healing motility are both examples of directional migration, a process which requires 
polarization of cytoskeletal and cellular components to facilitate directed organelle and vesicle 
transport. This ultimately establishes a persistent leading edge and represses random migration. 
Given that tubulin is a known substrate of HDAC6 and since microtubules (MTs) are known to 
play an important role in polarization of directionally migrating cells, we hypothesized that 
HDAC6 activity regulates important MT dependent aspects of directional cell motility.  
We were able to test this hypothesis by observing cellular polarization and organelle and 
vesicle transport in the presence or absence of HDAC6 activity using a wound-healing 
directional motility model. Experiments were carried out in HDAC6 null and wild type 
fibroblasts, and results were corroborated by pharmacological inhibition of HDAC6 activity. 
Loss of HDAC6 activity resulted in hyper-acetylation of tubulin, but not of Hsp90 or cortactin, 
two other HDAC6 substrates known to be involved in actin-mediated regulation of cell motility. 
Cells lacking HDAC6 activity showed significantly reduced wound-healing velocity but 
increased lamellipodial protrusions and random migration. These cells also failed to polarize 
  
their array of posttranslationally modified MTs as well as organelles such as their MT-organizing 
center (MTOC), Golgi apparatus, mitochondria, and vimentin filament array. Localizations of 
cortical dynein and its MT plus-end binding partner and processivity factor, p150Glued, known 
to be involved in MTOC reorientation via a MT capture mechanism, were also compromised in 
the absence of HDAC6 activity. In addition, polarized bi-directional transport of Golgi vesicles 
in motile cells was decreased. Retrograde and anterograde organelle transport were 
independently affected: Golgi reclustering during recovery from a Golgi inhibitor and 
mitochondrial trafficking in spreading cells, two canonical dynein- and kinesin- mediated events, 
were inhibited. Our results were specific to HDAC6 as re-expression in HDAC6 null cells 
rescued bi-directional Golgi vesicle transport. Testing the specific contribution of the acetylation 
state of lysine 40 of α-tubulin however, proved inconclusive as both re-expression of wild type 
α-tubulin and a non-acetylatable mutant equivalently rescued the Golgi vesicle motility defect.  
We also report initial data from our investigation into two parallel cell polarization 
pathways reported to orient a stable, modified MT array towards the direction of migration. 
Localizations of components of a MT-capture complex involved in stable MT array 
reorientation, cortical LL5β, and its MT plus-end tracking partner, CLASP2, were inhibited by 
loss of HDAC6, reminiscent of our results with cortical dynein and p150Glued. Paradoxically, 
localization of EB1, a MT plus-end binding protein involved in an mDia-mediated MT 
stabilization pathway was not affected. The localization of CLIP170, another MT plus-end 
binding factor related to p150Glued and known to be important for the recruitment of CLASPs to 
MT ends, was also not affected.   
These data provide novel insight into the role of HDAC6 in fibroblast motility showing 
that its activity is required for regulating MT-based cellular polarization and dynein- and kinesin-
  
mediated vesicular and organellar transport in directionally migrating cells. Our data also point 
to possible mechanisms by which deregulation of MT acetylation, by abrogating or inhibiting 
HDAC6 activity, inhibits directional motility and underscore the importance of this MT subset in 
establishing cellular polarization. We propose that HDAC6 activity modulates bidirectional 
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THE MICROTUBULE CYTOSKELETON 
MTs are dynamic cytoskeletal polymers present in all eukaryotes that are important in 
diverse cellular processes, including cell motility, axonemal-based ciliary and flagellar motility, 
intracellular transport, mitosis, and morphogenesis. In these roles MTs provide structural 
integrity to cells, allow for the separation of sister chromatids in mitosis, establish polarity in 
morphogenetic events like motility, form specialized structures like the spindle, axonemes, and 
neuronal processes, and function as tracks for intracellular transport. Moreover, these ubiquitous 
polymers are found throughout the entire cell, connecting all cellular proteins and organelles in 
signaling pathways. Their ability to polymerize and depolymerize quickly, and undergo rapid 
reorganization in response to various stimuli and cell cycle requirements, is critical to their 
function and requires precise temporal and spatial regulation. How MTs are regulated in order to 
perform the vast repertoire of functions associated with them is vital to understanding their 
distinct role in each function.   
 
MT Structure 
MTs are helical polymers composed of α and β tubulin heterodimers, the head-to-tail 
arrangement of which forms polar linear protofilaments (Fig. 1). Parallel protofilaments 
associate laterally to form curved sheets that close to create hollow MT cylinders with a standard 
outer diameter of approximately 25 nM. Lateral interactions between protofilaments in the 
resulting lattice are homologous (α-α or β-β), except at the MT ‘seam’ where tubulin dimers 
make heterologous (α-β) contacts (Krebs et al., 2005). This architecture forces the MT lattice 
into a conformation in which the protofilaments run straight, without winding, thereby 





α and β- tubulin monomers exhibit high sequence homology (~ 40%) (Luduena, 1998), and apart 
from slight differences in curvature, appear to be identical in high-resolution structural models 




Figure 1. Microtubules are composed of α and β tubulin heterodimers. Head to tail 
assembly leads to the formation of linear protofilaments, which laterally associate to form 
polar, hollow polymers with a diameter of 25 nm. 
 
 
The amino-terminal domain of each monomer binds GTP at a nucleotide-binding pocket, 
termed the N (non-exchangeable) site in α-tubulin that is buried at the intradimer surface, and the 
E (exchangeable) site in β-tubulin that is partially exposed to allow for nucleotide exchange 
(Nogales et al., 1998).  In polymerized MTs, the amino-terminal domains face the MT lumen and 
form a bumpy inner surface. The intermediate domain is proposed to mediate interactions with 
MT drugs, like the taxol-binding site in β-tubulin, while the carboxyl terminal domain forms a 
crest on the outside surface of the MT polymer. The highly acidic, carboxyl terminal tails, whose 





surface of MTs providing the main sites of interaction for a wide variety of MT-associated 
proteins (MAPs), including the MT motors, dyneins and kinesins.  
During protofilament polymerization, which is driven by a gain of entropy, the α-tubulin 
in the heterodimer being added contacts the exposed β-tubulin E-site in the previous dimer for 
GTP hydrolysis. This head-to-tail arrangement of the heterodimers in protofilaments imparts 
polarity to MTs. Although MTs from tissue culture cells can self-assemble in vitro (Bulinski and 
Borisy, 1979), in vivo MTs are nucleated in the cytoplasm from MT-organizing centers 
(MTOCs) (Mitchison and Kirschner, 1984b) or the Golgi apparatus (Efimov et al., 2007). The 
slow-growing or minus ends of each MT are affixed to the MTOCs or the Golgi apparatus, 
which protects them from depolymerization, while the fast- growing, more dynamic plus ends 
are free to polymerize and depolymerize in the cytosol. 
  
MT Dynamics 
In the test tube and in the cellular context, MTs alternate between phases of stochastic 
polymerization and depolymerization, known as dynamic instability (Mitchison and Kirschner, 
1984a). This rapid lengthening and shortening of MTs is important for many functions, as it 
allows the plus ends to explore the intracellular space and to increase contacts with cytoplasmic 
structures and proteins. This MT ‘search and capture’ mechanism enables the attachment and 
separation of chromosomes by kinetochores and the cortical capture of MTs leading to local MT 
stabilization and cell polarization (Gundersen et al., 2004) (Fig. 2). MT dynamics are also 
important in protrusive activity at the leading edge, focal adhesion turnover, and delivery of 
cargo to organelles and cell structures (Kaverina et al., 1999; Krylyshkina et al., 2002; Wittmann 







Figure 2. Cortical capture of MTs leads to selective MT stabilization and cellular 
polarization. In unpolarized cells (left), dynamic MTs bound by +TIPS, the MT plus-end 
binding proteins, search the extracellular space. Upon an external signal, for example, the 
accumulation of a chemo attractant or wounding which trigger cell motility, cortical 
factors redistribute and  initiate MT capture by interacting with +TIPs (middle). This 
localized MT capture leads to selective MT stabilization and MTOC reorientation which 
in turn cause global cellular polarization represented here by Golgi reorientation and 
polarized vesicle transport (right). Figure adapted from Gundersen et al. (2004). 
 
 
Dynamic instability is a property inherent to MT structure, resulting from the capacity of 
α and β tubulin to bind and hydrolyze GTP. Subunits that add to an existing protofilament 





site GTP ensures that the plus end of a growing MT possesses a GTP cap. The length of the GTP 
cap varies according to the relative rates of polymerization and GTP hydrolysis; MTs with slow 
polymerization rates lose their GTP caps. The GTP cap is thought to stabilize MTs by imposing 
structural constraints on the GDP-bound heterodimers in the body of the MTs, since GTP 
protofilaments appear to have a straight conformation and intrinsic stability, while GDP 
protofilaments, are curved, and thus subject to depolymerization (Nogales, 2001). Loss of the 
GTP cap is responsible for dynamic instability; it induces rapid depolymerization by exposing 
the less stably-bound GDP-tubulin subunits. MT dynamics are also regulated by interaction by 
several cofilamentous MAPs that stabilize subunit-subunit contacts within the protofilament 
(Konno et al., 2012). 
Studies of the structure of tubulin and MTs have provided vital information on binding 
mechanisms of drugs that affect MT dynamics. For example, Taxol, which binds to a site near 
the M-loop of β-tubulin, may stabilize MTs by altering lateral contacts that occur between the  
M-, H1-S2 and H3 loops of adjacent protofilaments, which face the MT lumen (Nogales, 2001). 
Taxol may also stabilize MTs by influencing interdimer longitudinal contacts within a 
protofilament. The drugs colchicine and nocodazole, which inhibit MT polymerization, bind the 
intradimer interface on the lumenal side, thus destabilizing longitudinal contacts. Vinblastine, 
another polymerization inhibitor, binds a region on β-tubulin exposed at the surface of MT ends, 
thus preventing further MT polymerization. Vinblastine and Taxol are widely used in 
chemotherapy because their capacity to inhibit MT dynamics impairs mitosis and motility. 
 





MAPs comprise a diverse group of proteins that regulate functional properties of MTs 
including MT dynamics and stabilization, cellular polarization and MT-dependent transport. The 
so-called cofilamentous MAPs, including MAP1, MAP2, MAP4 and Tau, were originally 
identified by in vitro polymerization/depolymerization purification schemes. These large, 
positively charged proteins ionically bind the carboxyl terminal domains of α and β tubulin and 
stabilize MT polymer (Nogales, 2001). Except for the ubiquitously expressed MAP4, these 
MAPs are primarily expressed in differentiated cells in neurons and glia, so they are excluded 
from our discussion here.  
Other MAPs serve as MT destabilizers. Op18/stathmin binds to MT plus ends and 
increases GTP hydrolysis; free Op18/stathmin dimers bind and sequester tubulin subunits, 
further destabilizing MTs. In addition, katanin and spastin enzymatically sever MTs, generating 
more free ends with exposed GDP-tubulin lattices that rapidly depolymerize. Finally, the Kin1 
kinesins potently depolymerize MTs by inducing a destabilizing conformational change in the 
tubulin lattice. 
Yet another group of MAPs, the +TIPs, interact preferentially with the growing, plus 
ends of MTs. +TIPs include  EB1,  APC, and CLASPs, which are involved in MT stabilization, 
as well as  the CAP-GLY domain-containing proteins, p150Glued, CLIP170, and Arp1, which 
are involved in recruiting dynein for intracellular transport (Akhmanova and Steinmetz, 2010). 
p150Glued also plays a well characterized role in MTOC reorientation (Dujardin et al., 2003). 
+TIPs interact with each other to form functionally different dynamic complexes at the plus ends 
of MTs, but there exists a hierarchy of binding wherein some +TIPs bind MTs directly to recruit 





various organelles and cellular structures (Fig. 2), or in MT interactions with other cytoskeletal 
structures, notably microfilaments.  
Finally, MT-activated ATPases of the kinesin and dynein families, serve as motor 
proteins that actively transport cargo bidirectionally along MTs (Mallik and Gross, 2004). Both 
types of motors transit along the outside surface of MT protofilaments; kinesins interact ionically 
with the carboxyl terminal tails of tubulin there. Transport of numerous organelles is important 




Functional diversity of MTs can be generated in the cell through differential expression 
of tubulin isotypes, through changes in the complement of MAPs that may alter MT dynamics 
and stabilization, and through post-translational modifications of tubulin (reviewed in Nogales, 
2001). The existence of several α- and β-tubulin isotypes expressed in eukaryotes led to the 
‘multitubulin hypothesis’ for creating functional diversity of MTs (Fulton and Simpson, 1976). 
To date, however, experimental evidence suggests that different isotypes are mostly 
interchangeable, with only modest functional differences that help in long-term differences that 
are implemented over several cell cycles, and usually irreversibly (Luduena, 1998). Hence, MT 
diversification via isoform-switching usually contributes to organogenesis or other differentiative 
events. All isotypes are highly homologous, with the carboxyl terminal acidic tails of  and  
tubulin being the most divergent among isoforms. In contrast, altered complements of MAPs and 





of α and β tubulin, contribute more significantly to the cells’ regulation of MT dynamics and 
function. 
 
MT stabilization and posttranslational modifications 
In undifferentiated vertebrate cells, stable MTs comprise a small subset of the total MT 
array, but form a polarized array early in the polarization process, for example, in differentiating 
neuronal and myogenic cells and in directionally migrating fibroblasts (Bulinski and Gundersen, 
1991) (see Fig. 2 for migrating cells). Temporal and spatial regulation of MT stabilization is 
thought to be important for directional migration and differentiation, perhaps because stable MT 
arrays serve as long-lived tracks for iterative intracellular transport events. Stable MTs also exist 
in specialized structures like cilia and flagella, where their stability may be important for 
intraflagellar transport.  
MT stabilization may be instigated via the persistence of a GTP cap, capture by a +TIP 
complex, or binding of cofilamentous MAPs. Stable MTs are thought to acquire different 
functions due to the posttranslational modifications they accumulate. Tubulin subunits within the 
MT polymer are subject to the action of post-translational modification enzymes that carry out 
lysine-40 acetylation, detyrosination, polyglutamylation, polyglycylation and ∆2- tubulin 
generation (Janke and Bulinski, 2011) (Fig. 3). All modifications except for Δ2-tubulin, which is 
formed by the additional cleavage of the glutamic acid residue exposed by detyrosination on -
tubulin, are reversible, and all except for α-tubulin lysine-40 acetylation, occur on the carboxyl 
terminus of - and/or -tubulin. Thus, carboxyl terminal modifications alter the surface of the 
MT, where they are then poised to modulate interactions with a diverse group of MAPs. Despite 





knowledge concerning the modifying/demodifying enzymes and their inhibitors has thwarted the 





Figure 3. Microtubule posttranslational modifications. Figure shows lysine-40 
acetylation, detyrosination, ∆2- tubulin, and polyglutamylation and polyglycylation side 
chains on an α-β tubulin heterodimer in MT polymer. All modifications, except lysine-40 
acetylation, occur on the cytoplasmic carboxyl-terminal tails of α or β tubulin where they 
affect interactions with a wide variety of MAPs. Lysine 40 acetylation occurs on the 





carboxyl terminal tails from representative mouse tubulin isotypes are shown to indicate 
positions of modifications. Figure adapted from Janke and Bulinski (2011). 
 
 
Detyrosination and acetylation predominate in the oriented stable MTs of directionally 
migrating cells, e.g., in fibroblasts and epithelial cells. Polarized acetylated and detyrosinated 
arrays (Fig. 4) are postulated to play important roles in signaling pathways during cell migration 
(Bulinski and Gundersen, 1991). The early elaboration of a stable, modified MT array oriented 
towards the direction of migration is thought to form a template for further polarization of cell 
contents and intracellular transport (Bulinski and Gundersen, 1991; Kirschner and Mitchison, 
1986) (also see Fig. 2). Detyrosination and acetylation are postulated to mark preferred MT 
tracks that polarize intracellular transport. Polarized transport to the plasma membrane 
contributes to membrane turnover during directional migration (Bergmann et al., 1983).  
Although detyrosination and acetylation demarcate the same population of stable MTs 
(Bulinski et al., 1988), the elaboration of the two modifications according to different timing and 
regulation (Chang et al., 2002; Gundersen et al., 1989; Quinones et al., 2011) argues that 
detyrosination and acetylation serve different functions during differentiation or motility. 
Moreover, detyrosination is an effect and not a cause of MT stability (Skoufias and Wilson, 
1998), unlike MT acetylation, in which a relationship between stability and modification is still 
not well understood. The roles of both detyrosination and acetylation in modulating membrane 
trafficking have been explored (Gurland and Gundersen, 1995; Hammond et al., 2010; Lin et al., 







Figure 4. MTs are stabilized and then modified at the leading edge in directionally 
migrating cells. Figure shows a representative motile cell from a fibroblast monolayer 
undergoing wound healing, in which MT stabilization, via an end-capping mechanism, 
for e.g., the MT capture of dynamic MTs by the leading edge (see Fig. 2), is followed by 
detyrosination and acetylation resulting in a polarized and modified stable MT array 
facing the leading edge. The early elaboration of a polarized, modified MT array is 
thought to form a template for further polarization of cell contents and intracellular 
transport. Note that while detyrosination and acetylation are independent modifications 
(Chang et al., 2002), they occur on the same subset of stabilized MTs. Dynamic MTs are 
depicted in black, while polarized, stable MTs are shown in red, detyrosinated MTs in 
blue, acetylated MTs in stippled red and a stable, detyrosinated and/or acetylated MT 








Detyrosination is a reversible posttranslational modification unique to tubulin, in which 
an unidentified tubulin carboxypeptidase (TCP) removes the genetically encoded carboxyl 
terminal tyrosines from polymerized α-tubulin subunits, thus exposing glutamic acid residues on 
the surface of MT polymers (reviewed in Janke and Bulinski, 2011) (see Fig. 3). As with all 
reversible post-translational modifications of tubulin, the modification cycle is completed by the 
reversal of the modification, in this case the tyrosination of depolymerized tubulin subunits by 
tubulin tyrosine ligase. Due to the high efficiency of this ligase, all newly polymerized MTs are 
composed only of tyrosine residues, such that presence of detyrosinated subunits ‘marks’ those 
MTs that have been stabilized.  
Despite the fact that the tyrosination enzyme, tubulin tyrosine ligase, was the first MT 
post-translational modification enzyme to be cloned and sequenced (Ersfeld et al., 1993), 
reagents to study the detyrosination reaction have been lacking. Only a partial purification of  the 
tubulin-specific tyrosine carboxypeptidase (TCP) (Argarana et al., 1980), has been reported to 
date. Thus, experiments to test the role of Glu MTs have been largely designed to use indirect 
methods.  For example, inhibition of Glu MT formation by incorporation of nitrotyrosine, a non-
cleavable tyrosine analog, blocked early differentiation events in myogenesis (Chang et al., 
2002). Similarly, microinjection of Glu tubulin antibody blocked kinesin-mediated vimentin and 
transferrin receptor transport towards the leading edge of migrating cells, respectively (Gurland 
and Gundersen, 1995; Lin et al., 2002). The interpretation of these results was that kinesin 





kinesin-1 for Glu MTs through in vitro (Liao and Gundersen, 1998) and in vivo (Konishi and 
Setou, 2009, and less directly, Hammond et al., 2010 ) studies.   
The CAP-GLY domains of MT +TIPs show decreased binding to Glu MTs (Akhmanova 
and Steinmetz, 2010; Badin-Larcon et al., 2004; Erck et al., 2005). Studies in yeast that express 
an α-tubulin mutant unable to be tyrosinated (Badin-Larcon et al., 2004), and mice lacking 
tubulin tyrosine ligase (Erck et al., 2005) showed that increased Glu MTs (and in mice, -2-
tubulin enriched MTs) mislocalize CLIP-170, but not EB1, from MT plus ends. Budding defects 
in the mutated yeast cells, which require dynein for budding, suggested that dynein motility is 
impaired in these cells. Since mice null for tubulin tyrosine ligase die shortly after birth and 
exhibit major neuronal defects (Erck et al., 2005) and since CLIP170 is known to link dynein to 
its cargo for retrograde transport (Perez et al., 1999), these data may also imply a dynein-
mediated transport defect in animals with increased Glu and/or -2-tubulin modified MTs. Thus, 
Glu MTs may enhance kinesin-based but decrease dynein-based MT transport. These data 
nonetheless provide evidence for the hypothesis that detyrosinated tubulin functions as a marker 
for altered intracellular transport along detyrosinated MTs. 
 
Acetylation 
Reversible acetylation of α-tubulin (LeDizet and Piperno, 1987) was first discovered in 
Chlamydomonas ciliary axonemes (L'Hernault and Rosenbaum, 1985), and on a few cytoplasmic 
MTs in Chlamydomonas, Drosophila, and mammalian cells (Bulinski et al., 1988; Piperno and 
Fuller, 1985b; Piperno et al., 1987). Unlike all other tubulin modifications, which occur at the 
carboxyl terminus of tubulin, acetylation occurs on the highly conserved amino terminal lysine 





the MT (Nogales et al., 1999). Despite extensive studies showing that increased acetylation of  
stable MTs correlates with many differentiation and polarization events  (Bulinski and 
Gundersen, 1991), the role(s) of this evolutionarily conserved modification have not been 
determined.  
Despite tubulin’s abundance in the cytoplasm, and the fact that it was the first 
cytoplasmic protein that was shown to be reversibly acetylated (Piperno et al., 1987), it has not 
been straightforward to decipher the role of acetylated MTs in any organism. Neither mutation of 
lysine 40 to a non-acetylatable residue in protists (Gaertig et al., 1995; Kozminski et al., 1993), 
nor overexpression of a non-acetylatable tubulin in C. Elegans (Fukushige et al., 1999) yielded 
obvious phenotypes in those organisms. Moreover, mice genetically null for the tubulin 
deacetylation enzyme, HDAC6, showed hyper-acetylated tubulin in most tissues, but they 
developed into adults and exhibited only subtle phenotypes (Lee et al., 2008; Zhang et al., 2008) 
that have yet to be fully characterized. 
Although tubulin acetylation appears to be unnecessary for cell and organism survival, 
the identification of the enzymes involved in reversible tubulin acetylation is beginning to 
uncover its functions and regulation in cellular processes. Confirmed α-tubulin lysine 
acetyltransferases are αTAT1 in mammalian cells, and MEC17 and αTAT2 in C.Elegans (Akella 
et al., 2010; Shida et al., 2010). αTAT1 was first identified by its interaction with the Bardet-
Biedl complex of proteins (the BBSome) required for genesis of the primary cilium; this 
implicated MT acetylation in development and/or function of cilia (Shida et al., 2010). 
Moreover, disruption of αTAT1 in Tetrahymena and zebrafish decreased MT stability and led to 
neuromuscular defects, respectively, while disruption of MEC17 disregulated touch sensitivity in 





reported as well, such as ARD1-NAT1 (Ohkawa et al., 2008), the elongator complex protein, 
ELP3 (Creppe et al., 2009; Solinger et al., 2010), and GCN5 (Conacci-Sorrell et al., 2010). 
However, the identification and verification of tubulin acetyltransferases is still underway, as the 
correlation between the activity of αTAT and MT acetylation is imperfect, and in vivo activity 
has thus far been rigorously demonstrated only for αTAT/MEC17 enzymes, not other putative 
acetyltransferases.   
Tubulin  deacetylation was definitively  shown to be carried out by the cytoplasmic 
histone deacetylase family member, HDAC6  (Hubbert et al., 2002). Sirtuin 2 (SIRT2) was also 
shown to deacetylate tubulin (North et al., 2003), but is present in small amounts and is most 
likely inactive in interphase cells (Hubbert et al., 2002; North et al., 2003). Accumulation of 
hyper-acetylated tubulin in HDAC6 null cells and tissues, further suggests that SIRT2 does not 
deacetylate tubulin in vivo (Zhang et al., 2008).  
 Pharmacological manipulation of HDAC6 activity, and consequently of MT acetylation 
level, also suggested a number of cellular functions of acetylated MTs (Haggarty et al., 2003; 
Hubbert et al., 2002; Matsuyama et al., 2002; Zhang et al., 2003). For example, increased MT 
acetylation levels were shown to impact MT-dependent functions such as MTOC reorientation 
and immune synapse formation in lymphocytes (Serrador et al., 2004), osteoclast maturation 
(Destaing et al., 2005), viral infection (Huo et al., 2011), cell cycle and cytokinesis (Wickstrom 
et al., 2010), ciliary assembly and function (Loktev et al., 2008), kinesin function (Hammond et 
al., 2010; Reed et al., 2006) and cell motility (Haggarty et al., 2003; Hubbert et al., 2002; 
Lafarga et al., 2012). However, definitive proof for these putative functions of MT acetylation 





We and others previously reported that MT hyper-acetylation modestly dampens MT 
dynamics (Matsuyama et al., 2002; Tran et al., 2007). The role of acetylation in MT stabilization 
has been controversial, though. Some studies assayed for a major shift in sensitivity to MT 
destabilizing drugs as a result of their increased acetylation; none was found (Haggarty et al., 
2003; Palazzo et al., 2003). Another study showed that protein-protein interactions, rather than 
catalytic activity, of HDAC6 results in decreased MT growth parameters (Zilberman et al., 
2009).  
We also determined that MT hyper-acetylation reduces focal adhesion turnover during 
cell motility (Tran et al., 2007); this turnover might be expected to result from altered MT 
dynamics, as highly dynamic MTs are necessary to mediate adhesion breakdown (Kaverina et 
al., 1999). Furthermore, increased MT acetylation was reported to destabilize MTs by recruiting 
the destabilizing MT severing protein katanin (Sudo and Baas, 2010). However, interpretation of 
this study was confounded by increased glutamylation within the same population of MTs, as 
post-translational glutamylation, not acetylation  has been shown to increases katanin’s severing 
activity in vitro (Lacroix et al., 2010). 
Perhaps the most striking function proposed for MT acetylation is augmenting motor 
binding and increasing intracellular trafficking, such that acetylation, like detyrosination, could 
serve as a marker for preferential intracellular transport. Kinesin-1 was reported to bind 
acetylated MTs with higher in vitro binding affinities, while in vitro kinesin-1 binding to, and 
velocity of transport on MTs polymerized from a non-acetylatable form of tubulin was 
dramatically reduced (Reed et al., 2006). This study also reported that an increased level of MT 
acetylation, and not other posttranslational modifications, paralleled an increase in polarized 





researchers reported conflicting data, demonstrating that acetylated MTs do not serve as 
preferential tracks for kinesin-1 transport in neurons, and increased MT acetylation is not 
sufficient to increase transport (Hammond et al., 2010). Hammond et al. (2010) concluded that a 
combination of MT modifications may enhance kinesin-1 transport, with the most critical 
modification being detyrosination; that detyrosination marks MTs for preferential kinesin 
transport in neurons was also shown by Konishi and Setou (2009).  
Parallel studies with BDNF, a dynein cargo, showed increased bidirectional transport of 
BDNF vesicles on acetylated MTs in neuronal cells and on MTs that were chemically acetylated 
at a variety of lysine residues in vitro (Dompierre et al., 2007). Thus, some studies suggest that 
lysine-40 acetylation of MTs affects anterograde and/or retrograde transport via kinesin or 
dynein in neurons, but the methods, data, and interpretations of these studies remain to be sorted 
out. 
 
MTs and directional migration 
Directional migration of cells is critical during embryonic development, wound healing, 
immune function, and invasiveness of metastatic cells (Ananthakrishnan and Ehrlicher, 2007). 
Directional migration requires the polarization of cytoskeletal and cellular contents so as to 
scaffold intracellular transport towards the leading edge of the motile cell (see Fig. 5 for a 
polarized migrating cell). Polarized trafficking enables transport of cytoskeletal, membrane and 
signaling components to the leading edge, facilitating proper assembly and turnover of proteins 
involved in the motility machinery (Wakida et al., 2010). In migrating cells, both actin and MT 
networks polarize and contribute to the polarization of other cellular components (Wittmann and 





movement. MTs, on the other hand, are required for polarization of the actin network and for 
persistent directionality of movement. Therefore, tight coordination of the actin and microtubule 
cytoskeletons, as well as membrane and adhesion dynamics, is critical for directional motility 





Figure 5. A polarized motile cell. Migrating cells polarize actin and stable, modified MT 





generating forces for forward movement, MTs are important for establishing cellular 
polarization. The redistribution of cortical factors to the leading edge causes MT capture 
via the +TIPs leading to selective MT stabilization and posttranslational modification. 
Stable, modified MTs instigate cellular polarization of organelles such as the MTOC and 
Golgi, as well as intracellular vesicular transport which is mediated by MT motors 
kinesins and dyneins in anterograde and retrograde directions, respectively. Focal 
adhesions form at the front of the cell and are turned over by dynamic MTs at the rear of 
the cell.  
 
 
 Actin polymerization at the leading edge creates protrusive forces that generate 
lamellipodial protrusions (Small et al., 1978). This protrusive activity is coupled with retrograde 
actin flow;  together these generate forces sufficient to push the cell forward (Waterman-Storer 
and Salmon, 1999). Adhesion formation at the leading edge of the cell and turnover at its trailing 
edge allow for cell-substrate adhesion de-adhesion cycles during movement. The actin 
cytoskeleton is regulated by activities of the Rho GTPases, RhoA, Rac1, and Cdc42, which each 
redistribute to specific compartments during migration: Rac1 and Cdc42 localize to lamellipodia, 
while RhoA is maintained in the cell body (Nobes and Hall, 1999). Thus Rac1 and Cdc42 are 
appropriately positioned to induce lamellipodial protrusions and cell polarization, respectively, 
whereas RhoA activity is in the correct location to regulate contractility and adhesion formation 
during motility. 
MTs play critical roles in the polarization of motile cells; they stabilize lamellipodia and 





whose MTs are disrupted lose lamellipodial polarity and ruffling, and increase random migration 
(Bershadsky et al., 1991; Glasgow and Daniele, 1994). MTs are hypothesized to play a role in 
polarizing cellular contents, as well as intracellular trafficking of vesicles and organelles during 
cellular motility, thereby further enhancing directional persistence. 
 
HDAC6, A MAJOR CYTOPLASMIC PLAYER 
The discovery that HDAC6 is the tubulin deacetylase (Hubbert et al., 2002) led to a 
number of initial reports linking MT acetylation to cell motility (Haggarty et al., 2003; Hubbert 
et al., 2002) immune cell function (Serrador et al., 2004), and kinesin-based transport (Reed et 
al., 2006). While the acetylation of tubulin, despite being the first cytoplasmic protein shown to 
be reversibly acetylated (Piperno et al., 1987), still does not have well characterized functional 
roles, HDAC6 has since emerged as a key cytoplasmic regulator of many important biological 
processes including cell migration, immune function, degradation and transport of ubiquitinated 
and misfolded proteins in response to cellular stress, as well as cancer and neurodegeneration 
(Aldana-Masangkay and Sakamoto, 2011; Valenzuela-Fernandez et al., 2008). 
Although tubulin is an abundant substrate whose acetylation/deacetylation is a potential 
regulator of the cytoskeletal function, the diverse processes regulated by HDAC6 are mediated 
by an impressive range of mechanisms that involve a growing list of substrates and interacting 
proteins (see Tables 1 and 2). The distinction of substrates vs. interacting proteins is important 
because HDAC6 can act in both deacetylase-dependent and -independent modes in cell motility 
of fibroblasts and lymphocytes, respectively, and in its role in the binding and clearing of 
ubiquitinated proteins (Cabrero et al., 2006; Hubbert et al., 2002; Kawaguchi et al., 2003). This 





cellular processes and in different cell types address multiple mechanisms and substrates via 
which HDAC6 may mediate its effects.  
 
Lysine acetylation and the acetylome 
Posttranslational modification of proteins is a major regulatory mechanism that increases 
the overall coding potential of the genome by generating functional diversity in cellular proteins 
(Walsh et al., 2005). Multiple aspects of a protein’s function during its cellular lifetime, 
including its folding, activity, stability, intracellular localization, and interactions with other 
proteins and nucleic acids, can all be modulated by posttranslational modifications (Soppa, 
2010). The most common modifications are phosphorylation, acetylation, ubiquitination, 
sumoylation, methylation, glycosylation, and proline isomerization (Yang and Seto, 2008). The 
potential for regulatory crosstalk between modifications is becoming more obvious; for example, 
ubiquitination and acetylation both occur on lysine residues and each can thus ‘lock’ the site 
from the other modification. 
Acetylation of proteins at the amino terminus or on the ε-amino group of an internal 
lysine, is thought to be the most common posttranslational modification in eukaryotes (Soppa, 
2010). N-terminal acetylation, which occurs on the α-amino group of methionine or the 
penultimate residue exposed after cleavage of methionine, is irreversible, well conserved, and 
widespread, occurring on as many as 90% of proteins (Helbig et al., 2010), yet its functional 
significance is not well understood. Acetylation on internal lysines, on the other hand, is often 
reversible and occurs on numerous cellular proteins (the so-called ‘acetylome’). Reversible 
acetylation has been shown to be involved in regulation of numerous pathways and processes. 





significance in cells has been proposed to rival that of protein phosphorylation (Choudhary et al., 
2009; Kouzarides, 2000). Accordingly, cells precisely regulate lysine acetylation of proteins. 
Reversible acetylation on internal lysine residues occurs on both nuclear and cytoplasmic 
proteins. Tubulin was the first cytoplasmic protein found to be acetylated (L'Hernault and 
Rosenbaum, 1985; Piperno and Fuller, 1985), followed by p53 (Gu and Roeder, 1997).  The 
addition of an acetyl moiety to a lysine side chain neutralizes the cationic charge on lysine to 
alter interactions with other proteins and with DNA (Soppa, 2010). Acetylation of histones, 
therefore, induces chromatin remodeling so that gene transcription can occur. However, 
acetylation can also cause either gene activation or inhibition, by acetylating transcriptional 
coactivators or repressors, respectively.  
Whether acetylation’s changing of the charge on -tubulin lysine 40 impacts protein-
protein binding is not known. This is further confounded by the fact that the site for acetylation 
on lysine 40 of α-tubulin, the acetylation site studied here, faces the MT lumen (Nogales, 2001). 
The discovery of novel acetylation sites on both α- and β-tubulin may be functionally relevant; 
these are expected to have different roles in MT function (Choudhary et al., 2009; Chu et al., 
2011). However, most of these sites have not yet been verified to exist in vivo, and thus will not 
be considered here. The exception is acetylation on lysine 252 of β-tubulin, which does occur in 
vivo (Chu et al., 2011), but whose physiological significance still remains to be determined. 
Moreover, acetylation of lysine 252 in unpolymerized β-tubulin is carried out by a novel tubulin 
acetyltransferase, SAN, and appears to block MT polymerization. Given how different the 
properties of acetylation of lysines 252 and 40 are, we will confine our discussion here to the 






Histone deacetylases and HDAC6 
Histone deacetylases (HDACs) and acetyltransferases (HATs), enzymes first shown to 
modify histones, are now known to regulate reversible lysine acetylation of several nuclear and 
cytoplasmic proteins (Sadoul et al., 2011). As the number of non-histone and cytoplasmic 
proteins known to be acetylated continues to grow these enzymes are also referred to as lysine 
deacetylases (KDACs) and acetyltransferases (KATs). Lysine acetylation occurs on the epsilon-
amino group of internal lysine residues in proteins and serves to neutralize the inherent positive 
charge of this amino acid.  
There are 18 known members of the mammalian HDAC family; these are classified into 
four groups based on their homology with yeast orthologues (Witt et al., 2009) (Fig. 6). Despite 
high homology, HDACs are generally not considered to be functionally redundant (Dokmanovic 
et al., 2007). Moreover, they co-exist and interact with other HDACs within multi-subunit 
complexes (Zhang et al., 2003b). Class I, II, and IV encompass classical HDACs dependent on 
the zinc ion, which is essential for the removal of the acetyl moiety via a mechanism of charge 
transfer within the HDAC molecule (de Ruijter et al., 2003). Class I HDACs, homologs of yeast 
Rpd3, a global gene regulator and transcriptional repressor, include HDACs 1, 2, 3 and 8. These 
ubiquitously expressed HDACs are active in nuclear transcriptional complexes, in which they 
regulate gene repression. Phenotypes of HDAC-null mice show that HDAC1- and 3- nulls are 
embryonic lethals, while HDAC2-null mice die perinatally of severe cardiac defects (Witt et al., 
2009). 
The Class II HDACs related to yeast Hda1 are further subdivided into Class IIa, which 
includes HDACs 4, 5, 7 and 9, and Class II b, which includes HDACs 6 and 10 (Sadoul et al., 





Class IIa-null mice are viable, with the exception of HDAC7, which is embryonic lethal due to 
defects in endothelial cell-cell adhesions (Witt et al., 2009). HDAC4 null mice show 
developmental bone ossification defects and exhibit early onset chondrocyte hypertrophy, while 





Figure 6. The histone deacetylase (HDAC) family. The figure shows the catalytic 





(HDACs 4, 5, 7 and 9), IIb (HDACs 6 and 10) and IV (HDAC11), and of SIRT2, which 
is shown as a representative member of the Class III sirtuins (SIRTS 1-7). The 
structurally distinct deacetylase domains of the zinc-dependent classical HDACs and the 
NAD-dependent SIRT2 are depicted with red and green boxes, respectively. 
Representations reflect the relative sizes of these HDACs. The number of amino acid (aa) 
residues and the inhibitory profiles of standard HDAC inhibitors are shown to the right. 
Figure adapted from Bolden et al. (2006). 
 
  
All Class II HDACs, except HDAC6, which is predominantly cytoplasmic (Hubbert et 
al., 2002), are able to shuttle between the nuclear and cytoplasmic compartments (Sadoul et al., 
2011). HDACs 4 and 6, however, are the sole HDACs so far known to have cytoplasmic 
substrates. HDAC4 has four known substrates, MLP (Gupta et al., 2008), DNAJB8 (Hageman et 
al., 2010), HIF1α (Geng et al., 2011), and connexin 43 (Colussi et al., 2011), which regulate 
muscle contraction, suppression of cytotoxic protein aggregate formation, cancer cell hypoxia-
induced angiogenesis, and GAP junction formation, respectively. 
HDAC6 is a unique member of the HDAC family and belongs to a subgroup sometimes 
referred to as Class IIb. HDAC6 is structurally and functionally divergent from other HDACs 
and resides almost exclusively in the cytoplasm (de Ruijter et al., 2003). It is the only HDAC 
with two functional catalytic domains, a nuclear exit signal and an ubiquitin binding domain. 
Surprisingly, despite the loss of HDAC6 function in several important biological processes and 
high levels of hyper-acetylated MTs, HDAC6 null mice are viable with only minor behavioral 





being noted thus far in comparison with WT littermates. HDAC6-specific substrates include α-
tubulin and other cytoplasmic substrates and will be discussed in more detail below. 
HDAC10, also in Class IIb, is the HDAC structurally most related to HDAC6. However, 
the second catalytic domain in HDAC10 is not functional and it is not clear whether HDAC10 
works as a deacetylase in vivo (de Ruijter et al., 2003). HDAC10 interacts with deacetylated 
proteins including cytoplasmic Hsp70 (Park et al., 2008; Yao and Yang, 2011). Whether these 
are substrates of HDAC10 remains to be determined. HDAC 11, with structural features unique 
to HDACs, is assigned to its own class, Class IV (Witt et al., 2009). HDAC6 has been shown to 
interact with both HDAC10 and 11 (Gao et al., 2002), but functions of HDACs 10 and 11 are 
largely unknown and null mice have yet to be generated and analyzed. 
Finally, the Class III HDACs, also known as sirtuins, are related to yeast Sir2 and form a 
functionally and mechanistically distinct class (Michan and Sinclair, 2007). The dependence of 
this class on NAD for catalysis links these enzymes to the cell’s energy stores and sirtuins are 
known to regulate metabolic pathways (Yao and Yang, 2011). Sir2 in yeast is a transcriptional 
repressor and regulates longevity, chromosomal stability and DNA repair and recombination. 
The seven mammalian homologs, SIRTs 1-7, also regulate longevity, caloric restriction, DNA 
repair, and tumorigenesis (Michan and Sinclair, 2007). 
SIRT2 is a Class III HDAC relevant to studies of HDAC6 since SIRT2 is also 
predominantly localized to the cytoplasm, is capable of deacetylating α-tubulin and  is shown to 
interact with HDAC6 (North et al., 2003). SIRT2 can however, translocate to the nucleus where 
it deacetylates p53, histones and p300, an acetyltransferase, among others (Michan and Sinclair, 
2007). SIRT2 is abundant in the brain where it may impinge upon MT-dependent processes (Yao 





thought to be active in interphase cells as it is present at a low level upregulated during mitosis 
and functions as a checkpoint protein to regulate proper mitotic exit (Dryden et al., 2003; 
Vaquero et al., 2006).  
The role of HDACs as global transcriptional modulators of cell differentiation, cell cycle 
and apoptotic events associates their aberrant regulation to several pathologies, especially 
cancers. HDAC inhibitors, which impact cell growth, induce terminal differentiation, and show 
greater cytotoxicity towards tumor cells, are promising therapeutic candidates; in fact, numerous 
clinical trials are in process for cancer (Ververis and Karagiannis, 2011). In addition, HDAC 
inhibitors are being investigated for use in neurodegenerative, infectious and cardiac diseases. 
Inhibitors of the classical HDACs typically work by chelating the zinc ion bound at the base of 
the catalytic pocket thereby disrupting the charge-relay system within the molecule. There are 
five classes of inhibitors for the classical HDACs. Short-chain fatty acids like butyrate and 
valproic acid, hydroxamic acids like TSA and SAHA, benzamides like MS-275, cyclic 
tetrapeptides like trapoxin and FK228, and electrophilic ketones (de Ruijter et al., 2003; Gallinari 
et al., 2007) (see Fig. 6 for the specificity of the widely-used inhibitors). Sirtuins, on the other 
hand, can be non-competitively inhibited by nicotinamide, a by-product of the deacetylation 
reaction, or by NAD analogs, including specific small molecule inhibitors like sirtinol that 
competitively inhibit NAD-requiring processes (Spange et al., 2009).  
 
HDAC6 Domains 
HDAC6 is the only member of the HDAC family with two functional catalytic domains 
(Fig. 7), making it the largest HDAC with 1216 amino acids in humans (Grozinger et al., 1999; 





duplication event during evolution as the two domains are highly homologous and conserved 
across species (Boyault et al., 2007). Whether one or both domains contribute to the 
deacetylation functions in HDAC6 has been controversial. Using catalytic point or deletion 
mutants, one group reported that both domains possess HDAC activity, but only the second 
domain possesses tubulin deacetylase (TDAC) activity (Grozinger et al., 1999; Haggarty et al., 
2003). Others reported that the second domain alone is responsible for all HDAC and TDAC 
activities, with the first domain being non-functional (Zou et al., 2006). Finally, a third group 
used deletion and multi-site catalytic core mutants to show that the presence and integrity of the 
catalytic cores of both domains are critical to all deacetylase activities of HDAC6 (Zhang et al., 



















Figure 7. HDAC6 domain map. The figure shows the organization of HDAC6 domains as 
marked: NLS, nuclear localization signal, that is masked under most conditions; NES, 
        




















nuclear exclusion signal, a unique, potent conserved nuclear exit signal; CAT, catalytic 
sites, the two fully functional HDAC6 catalytic domains that deacetylate α-tubulin, 
Hsp90 and cortactin among other identified substrates; ER, Esa1-Rpd3 motifs, conserved 
substrate recognition regions present in both catalytic domains; DMB, dynein motor 
binding domain; SE14, serine glutamate tetradecapeptide repeat motif, a novel repeat 
motif which ensures cytoplasmic anchoring; and ZnF-UBP, zinc finger ubiquitin binding 
protein or BUZ domain, that mediates binding to ubiquitinated proteins  
 
 
Additional features also affect the deacetylase properties of HDAC6. Mutations in 
conserved substrate recognition regions, the Esa1-Rpd3 (ER) motifs present in both catalytic 
domains, showed that the ER motif in the second domain is critical for HDAC and TDAC 
activity (Zhang et al., 2006). Mutations in the ER motif of the first domain only affected HDAC 
and TDAC activities modestly, although greater decrements were observed in tubulin 
deacetylation. The precise length of the linker region between the two catalytic domains is also 
critical for HDAC6 activity as reducing this linker by even 5 amino acids was sufficient to 
dramatically reduce activity. Again, TDAC activity was more sensitive to alterations in the 
length of the linker region. This linker region’s sensitivity may be one reason for the conflicting 
results when others tested each catalytic domain separately. Furthermore, experiments with 
artificial chimeric proteins with different HDAC domains showed that the second domain of 
HDAC6 is indispensable for its activity. TSA, a Class I and II HDAC inhibitor, as well as  
tubacin, an HDAC6-specific inhibitor, have also been shown to bind to the second domain of 





Given these data and the fact that no activity of HDAC6 towards histones has been 
shown in vivo, it may be that the second domain is critical for cytoplasmic substrate recognition 
and catalytic activity. Regardless of the mechanism, the presence of two catalytic domains no 
doubt confers HDAC6 with its unique biological properties and expands the diversity of its 
substrates in the cytoplasm. In support of this, binding of HDAC6 with different interacting 
proteins and substrates can either occur through a single domain, with different proteins 
preferring one domain over the other, or through both deacetylase domains (Azuma et al., 2009; 
Jiang et al., 2008; Lafarga et al., 2012; Wickstrom et al., 2010; Wu et al., 2010; Zhang et al., 
2007; Zhang et al., 2003b). The presence of two domains may be important for histone 
deacetylation in vivo as well as many HDACs co-exist in active complexes and experiments with 
artificial chimeric proteins with two domains lead to de novo activity (Zhang et al., 2006). 
HDAC6 has other features important for its function as well. What is called a 
cytoplasmic retention signal is actually mediated by a potent, conserved nuclear exit signal 
(NES) on the HDAC6 amino-terminus, a signal unique to HDAC6. In humans, stable 
cytoplasmic localization of HDAC6 is ensured by an additional SE14 domain, which is a novel 
tetradecapeptide repeat motif, and that provides cytoplasmic anchoring (Bertos et al., 2004). 
HDAC6 also contains an intrinsic amino-terminal nuclear localization signal (NLS) (Verdel et 
al., 2000). This NLS  appears to be masked under most conditions; nuclear localization is rare 
occurring only under certain conditions like cell cycle arrest or in certain cancers (Riolo et al., 
2012; Verdel et al., 2000; Westendorf et al., 2002; Zhang and Kone, 2002). NLS and nuclear exit 
signals have been shown not to be required for HDAC6 activity.  
HDAC6 has been mapped to show a small domain responsible for interacting directly 





adjacent to the second deacetylase domain of HDAC6 (see Figure 7). Finally there is a cysteine 
and histidine rich, ubiquitin-binding zinc finger domain, ZnF-UBP, also known as the BUZ 
domain, on the carboxyl-terminal end of HDAC6 (Grozinger et al., 1999; Verdel and Khochbin, 
1999). The BUZ domain is highly homologous to those found in several ubiquitin binding 
proteases (Seigneurin-Berny et al., 2001). However, it is unique to HDAC6 and it mediates the 
novel HDAC6 response to cellular stress and injury; i.e., clearing of ubiquitinated and misfolded 
proteins. The BUZ domain of HDAC6 possesses the highest known affinity for ubiquitinated 
proteins (Boyault et al., 2006) and can bind both mono and poly ubiquitinated proteins (Boyault 
et al., 2006; Hook et al., 2002; Seigneurin-Berny et al., 2001). This high-affinity binding is 
thought to be important in stabilizing poly-ubiquitinated proteins. Importantly, the binding of 
ubiquitinated proteins does not affect the concurrent deacetylase activities of HDAC6 
(Seigneurin-Berny et al., 2001). The BUZ domain is also implicated in the MT-dependent 
transport of misfolded and ubiquitinated proteins to lysosomal and aggresomal compartments, as 
it has been shown to link cargo to dynein motors (Boyault et al., 2007; Kawaguchi et al., 2003). 
 
Inhibitors 
HDAC6 shows selective sensitivity to classical HDAC inhibitors (see Fig. 6). It is 
inhibited by the hydroxamic acids TSA and SAHA, but shows no response to treatment with the 
short chain fatty acid butyrate or the cyclic tetrapeptides trapoxin and FK228 (Furumai et al., 
2001; Guardiola and Yao, 2002; Hubbert et al., 2002; Matsuyama et al., 2002). This selective 
drug resistance is due to the presence of the duplicated catalytic domain as HDAC10 displays a 
similar resistance (Guardiola and Yao, 2002) and provides an indirect way to assay the activity 





The development of a specific small molecule inhibitor of HDAC6, tubacin (Haggarty et 
al., 2003), which is as potent as TSA in inhibiting chemotactic invasion motility of fibroblasts 
(Tran et al., 2007), and its congenor, tubastatin (Butler et al., 2010), have been critical in 
investigating HDAC6-specific functions. Crucially, tubacin inhibition may be specific for α-
tubulin as Hsp90, cortactin and the in vitro substrate, histones, were not affected by treatment 
with this inhibitor (Lafarga et al., 2012; Tran et al., 2007). Two additional types of HDAC6-
specific inhibitors have recently been reported, mercaptoacetamides, and thiolate analogs (Li et 
al., 2011b). Inhibition with mercaptoacetamides and thiolate analogs has been shown to confer 
neuroprotective and anticancer properties, respectively. 
 
Substrates 
HDAC6 has been shown to deacetylate the following cytoplasmic substrates to date: α-
tubulin (Hubbert et al., 2002), Hsp90 (Kovacs et al., 2005), cortactin (Zhang et al., 2007), β-
catenin (Li et al., 2008), peroxiredoxins I and II (Parmigiani et al., 2008), and survivin (Riolo et 
al., 2012) (see Table 1). The deacetylation of α-tubulin, Hsp90 and cortactin are involved in 
regulating invasion motility (Hubbert et al., 2002; Kovacs et al., 2005; Zhang et al., 2007). The 
deacetylation of Hsp90, a vital cellular chaperone, is also involved in the induction of heat shock 
transcription factors in response to cellular injury and stress. β-catenin deacetylation by HDAC6 
is required for its nuclear localization and activation of target genes involved in cell proliferation 
in response to EGF signaling (Li et al., 2008). The deacetylation of the peroxiredoxins, PrxI and 
II, which can induce apoptosis, is important in the regulation and balancing of their redox 
activities and in decreasing hydrogen peroxide cytotoxicity (Parmigiani et al., 2008). Survivin is 





2012). The nuclear deacetylation of survivin by HDAC6 leads to its cytoplasmic shuttling where 
it induces cell death in breast cancer cells.  
Additionally, HDAC6 has also been shown to deacetylate the endoplasmic reticulum 
(ER) protein GRP78 (Rao et al., 2010), which dissociates from the ER upon cellular stress, and 
Ku70 (Subramanian et al., 2011), a factor that regulates apoptosis, in breast cancer and 
neuroblastoma cells, respectively. HDAC6 also deacetylates the HIV viral Tat protein important 
in HIV infection (Huo et al., 2011). 
 
Table 1. Cytoplasmic HDAC6 substrates and their related biological functions.  
Adapted from Valenzuela-Fernandez et al., 2008 
 
 
Substrates Related biological functions 
Motility-related 
α-tubulin 
MT-dependent cell migration; intracellular transport; immune 
synapse formation; viral infection; cell cycle and cytokinesis; 
myogenesis 
 
Cortactin actin-dependent cell migration 
Hsp90 actin-dependent cell migration; chaperone; heat shock response 
Non-motility related 
β-catenin activation of target genes in cell proliferation 
PrxI/II 
regulation of redox activities; hydrogen peroxide cytotoxicity; 
apoptosis 
Survivin apoptosis; cell proliferation 
GRP78 ER misfolded-protein stress response 
Ku70 apotosis in cancer and neuroblastoma cells 







In addition to having many deacetylation substrates, HDAC6 interacts with several 
cellular proteins. Many of these co-exist in multi-subunit complexes with HDAC6 (see Table 2). 
It is striking that a significant proportion of these interacting proteins are regulators or 
components of the MT cytoskeleton and/or are involved in the regulation of cell migration. 
HDAC6 interacts with β-tubulin through either of its deacetylase domains (Zhang et al., 2003b). 
This interaction is independent of its catalytic activity or its inhibition and is unaffected by 
treatment with TSA. Moreover, HDAC6 associates with both the tubulin dimer and polymerized 
MTs (Zhang et al., 2003b) and colocalizes with the Ac MT subset (Hubbert et al., 2002). The 
interaction of HDAC6 with its substrate, α-tubulin, to which it can independently bind via its 
catalytic domains, is thought to be mediated through the HDAC6-β-tubulin interaction (Zhang et 
al., 2003b).  
HDAC6 also interacts with MT +TIPs, which are known modulators of MT dynamics 
and function. Immunoprecipitation experiments have thus far identified p150glued (Hubbert et 
al., 2002; Kawaguchi et al., 2003), Arp1, and EB1 (Zilberman et al., 2009) as HDAC6-
interacting proteins. The EB1 interaction was further determined to occur through the N- and C-
terminal domains of HDAC6 that are not involved in deacetylation. HDAC6 also directly 
associates with the MT motor dynein (Kawaguchi et al., 2003). This interaction is mediated 
through a specific dynein-binding domain that is adjacent to the second deacetylase domain of 
HDAC6 (see Figure 7). The CAP-GLY domain proteins, p150glued and Arp1, are both subunits 
of dynactin, a regulatory complex of dynein (Vaughan, 2005), and HDAC6 interactions with 





interactions of HDAC6 with dynactin and dynein have been shown to mediate the MT-based 
transport of ubiquitinated and misfolded proteins to aggresomes. 
 
Table 2. Cytoplasmic HDAC6 interacting proteins and their related biological functions.  
Adapted from Valenzuela-Fernandez et al., 2008 
Proteins            Related biological functions 
Tubulin and MAPs  
β-tubulin α-tubulin deacetylation; binding to MTs; MT dynamics 
p150glued intracellular transport; aggresome formation; dynein adaptor 
EB1 regulation of MT dynamics; stabilization 
Arp1 regulation of MT dynamics; intracellular transport; dynein adaptor 
Dynein intracellular transport; aggresome formation 
Inhibitory upstream regulators 
CYLD 
cell migration; MT polymerization; cell cycle and cytokinesis; tumor 
invasiveness 
IIp45 cell migration; HDAC6 stability; mitosis; tumor suppressor 
TPPP/p25 
cell migration; MT bundling and dynamics; aggresome formation; 
neurodegenerative disease 
Tau MT stabilization; aggresome formation; neurodegenerative disease 
EGFR EGF-dependent signaling; EGFR degradation and recycling 
p300 cell migration 
Dysferlin myogenesis 
Activating upstream regulators  
mDia2 MT and actin dynamics; cell migration; osteoclast maturation 
GSK3β MT and actin dynamics; kinesin-based MT transport 





Table 2 continued 
 
Proteins              Related biological functions 
Cellular stress response proteins  
Parkin ubiquitin-aggresome pathway 
p97/VCP ubiquitin-aggresome pathway 
PLAP ubiquitin-aggresome pathway 
Ubiquitin ubiquitin-aggresome pathway; proteasomal degradation 
Cancer-related  
Erα breast cancer tumor invasiveness and proliferation 
BRMS1 breast cancer tumor invasiveness and proliferation 
HIF1α tumor invasiveness; angiogenesis; hypoxia 
Miscellaneous 
Bcl-3 CYLD-mediated cell cycle delay 
BBIP10 
ciliogenesis; MT acetylation, polymerization and stability; 
centrosome cohesion 
PP1 regulation of Akt phosphorylation; cell migration and apoptosis 
HDACs 
SIRT2 deacetylation of α-tubulin; mitosis; cytokinesis 
HDAC10 PP1 regulation 





Another major group of HDAC6-interacting proteins has been identified to serve as 
inhibitory upstream regulators of its activity. Of these, CYLD, a deubiquitinase and tumor 





(Wang et al., 2011; Wu et al., 2010), TPPP/p25, tubulin polymerization promoting protein 
(Tokesi et al., 2010), EGFR (Deribe et al., 2009; Han et al., 2009) and p300, a histone 
acetyltransferase (Han et al., 2009) are all known cell migration regulators that are likely to 
regulate the role of HDAC6 in cell motility. Moreover, interactions of HDAC6 with TPPP/p25 
and tau are shown to be involved in aggresome formation in response to cellular stress (Guthrie 
and Kraemer, 2011; Perez et al., 2009; Tokesi et al., 2010), while dysferlin, a transmembrane 
protein that binds HDAC6 and α-tubulin and regulates the deacetylation reaction, links HDAC6 
function to  myogenesis (Di Fulvio et al., 2011). 
Only a few interacting proteins thus far have been shown to stimulate HDAC6 activity. 
These are also implicated in regulating cell migration via their effects on the MT cytoskeleton 
and include the Rho effector, mDia2, glycogen synthase kinase β (GSK3β), and the G protein 
coupled receptor kinase 2 (GRK2) (Chen et al., 2010; Destaing et al., 2005; Lafarga et al., 2012). 
mDia1 and mDia2 are formin homology proteins that are involved in distinct actin nucleation 
and MT stabilization pathways (Bartolini et al., 2008; Eng et al., 2006; Palazzo et al., 2001a; 
Wen et al., 2004). Thus, through both its enzymatic activity and its binding partners, HDAC6 has 
been hypothesized to coordinate the MT and the actin cytoskeletons, respectively. For example, 
mDia2 binds to and stabilizes MTs directly (Bartolini et al., 2008) and can also bind either of the 
two deacetylase domains of HDAC6 (Destaing et al., 2005). It is thought that mDia1 also 
interacts with HDAC6 (Bershadsky et al., 2006). In migrating fibroblasts, mDia1 regulates MT 
stabilization towards the leading edge by the plus end binding proteins, EB1 and APC (Wen et 
al., 2004).  
Like mDia, regulation of GSK3β affects many MT-dependent processes. GSK3β is 





GSK3β is negatively regulated by mDia. It is also involved in the CLASP2- mediated MT 
stabilization pathway (Eng et al., 2006; Lansbergen et al., 2006; Wen et al., 2004). A recent 
paper has implicated GSK3β regulation of HDAC6 in kinesin-1 mediated mitochondrial 
transport in neurons (Chen et al., 2010). Furthermore, GSK3β may also coordinate the actin and 
MT networks required for efficient cell migration via GSK3β’s regulation of the interaction 
between CLASP2 and IQGAP1, which can bind both actin and MTs (Watanabe et al., 2009). 
Finally, GRK2 has recently been shown to be a major stimulator of HDAC6 tubulin deacetylase 
activity that is important in cell migration (Lafarga et al., 2012). 
HDACs are known to interact with protein phosphatases that regulate cell proliferation 
and transformation. The interaction between HDAC6 and protein phosphatase 1 (PP1) is of 
interest as TSA has been shown to physically disrupt this interaction (Brush et al., 2004). The 
only other instance in which an HDAC inhibitor physically disrupts binding is the HDAC6 
inhibitor, tubacin, which disrupts dynein-HDAC6 binding (Hideshima et al., 2005). HDAC6 
activity is required in order for HDAC6 to complex with PP1, which is also active in the 
complex (Brush et al., 2004). The release of PP1 upon TSA treatment has been shown to cause 
dephosphorylation of Akt, which also plays a role in cell migration (Brush et al., 2004; Chen et 
al., 2005; Zhou et al., 2006).  
HDAC6 interacts with several factors involved in cancer metastasis and invasiveness, 
including the estrogen receptor alpha (ERα) (Azuma et al., 2009), the breast cancer metastasis 
suppressor 1, BRMS1 (Hurst et al., 2006), and the Hypoxia-Inducible Factor 1α, HIF1α (Qian et 
al., 2006). HDAC6 also interacts with ubiquitin, parkin, the chaperone p97/VCP and the 
phospholipase PLAP2 all of which are involved in the ubiquitin-aggresome pathway triggered by 





involved in ciliogenesis. The HDAC6-mediated roles of these interacting proteins are discussed 
in more detail below. 
As outlined here, almost all known HDAC6-interacting proteins are functionally linked to 
the MT cytoskeleton and effect HDAC6-mediated regulation of MTs in cell migration. It is 
significant that HDAC6 interacts with several CAP-GLY proteins; these are a subset of MT plus-
end binding proteins (+TIPs) that possess CAP-GLY domains (Kawaguchi et al., 2003; 
Wickstrom et al., 2010; Zilberman et al., 2009). HDAC6 also interacts with transcriptional 
activators like NF-κB and Runx2 to modulate target gene repression (Westendorf et al., 2002; 
Zhang and Kone, 2002). Moreover, farnesyltransferase, a prenylating enzyme, is found in a 
complex with HDAC6 on MTs and though this enzyme does not interact directly with HDAC6, 
its activity modulates HDAC6 activity (Zhou et al., 2009). Finally, HDAC6 also interacts with 
SIRT2 (North et al., 2003), and HDACs 10 and 11(Gao et al., 2002), although the functional 
consequences of these interactions are less well understood. 
 
Role in cell motility 
The localization of HDAC6 to the leading edge lamellipodia of fibroblasts that have been 
stimulated with growth factors provided the first clue that HDAC6 is involved in the regulation 
of cell motility (Gao et al., 2007; Hubbert et al., 2002). Overexpression of HDAC6, but not of a 
catalytically inactive mutant, increased while HDAC6 pharmacological or genetic inhibition 
significantly decreased chemotactic motility (Gao et al., 2007; Haggarty et al., 2003; Hubbert et 
al., 2002; Tran et al., 2007). These results demonstrate that HDAC6 catalytic activity is required 
for the regulation of fibroblast cell motility. Moreover, tubacin, which increases levels of Ac 





2012), was shown to equivalently inhibit fibroblast chemotactic motility as compared with TSA 
(Tran et al., 2007), suggesting that tubulin may be the major hyper-acetylated protein underlying 
these effects. In support of this, we have previously shown that the hyperacetylation of MTs in 
pharmacologically inhibited or genetically null HDAC6 fibroblasts imparts a moderate 
stabilization to cellular MTs (Tran et al., 2007). Since HDAC6-inhibited or -null cells also show 
increased adhesions and decreased adhesion turnover, and since MT dynamics have been shown 
to be critical for regulating adhesion turnover (Kaverina et al., 1999), these results provide the 
first mechanism for a MT-dependent role of HDAC6 activity in chemotactic invasion of cells.  
GRK2, which also binds β-tubulin (Pitcher et al., 1998),  has recently been identified as a 
major player in HDAC6-mediated modulation of directional migration of fibroblasts and 
epithelial cells (Lafarga et al., 2012). GRK2 and HDAC6 were shown to colocalize in the 
lamellipodia at the leading edge of migrating cells, and HDAC6 activity was shown to be 
stimulated by GRK2 phosphorylation, thus regulating MT acetylation levels in these regions. 
Inhibition of HDAC6 by GRK2 mutation impaired cell migration and protrusive activity. 
Furthermore, a tight regulation of Ac MT levels by the GRK2-HDAC6 interaction was found to 
be important for both early and late phases in spreading cells. Cortactin acetylation was unaltered 
by HDAC6 activity, however, a role of the actin network cannot be ruled out as Hsp90 
acetylation was not investigated in this study. GRK2 has also been shown to regulate cell 
motility via integrin activation in the Rac/PAK/MEK/ERK1/2 signaling pathway that affects 
downstream actin and focal adhesion remodeling (Penela et al., 2008). 
However, Zilberman et al. reported that it was HDAC6 level and not activity that 
suppresses MT dynamics, suggesting that MT acetylation does not affect stabilization of MTs 





motility also explicating mechanisms involving a role of the actin cytoskeleton instead (Gao et 
al., 2007; Zhang et al., 2007). Cortactin and Hsp90, like HDAC6, localize to F-actin enriched 
ruffles and lamellipodia upon growth factor stimulation. HDAC6-mediated deacetylation of 
Hsp90 is critical for cell motility and ruffle formation; only a ‘non acetylatable’, and not an 
acetylation mimetic mutant of a critical lysine residue in Hsp90 rescued ruffle formation in 
HDAC6 null cells (Gao et al., 2007). Hsp90 deacetylation was also shown to be important in 
macropinocytosis, a process important for ruffle formation. Moreover, HDAC6 and Hsp90 were 
shown to stimulate ruffle formation by activating Rac1, a major actin effector of cell migration.  
The fact that overexpression of WT Hsp90 in HDAC6 -null cells only partially rescued 
ruffle formation indicated that other factors are involved in this process. Cortactin is a Rac1-
regulated, F-actin binding protein that stimulates actin polymerization and branching by 
interacting with the actin-nucleating complex, Arp2/3 (Zhang et al., 2007). F-actin 
polymerization leads to membrane ruffling and leading edge protrusions that are intrinsic to cell 
migration (Wittmann and Waterman-Storer, 2001). In an elegant study using non acetylatable 
and acetylation mimetic mutants, Zhang et al. showed that only deacetylated cortactin could bind 
and localize to the F-actin-rich membrane ruffles to stimulate migration (2007). Cortactin binds 
HDAC6 and F-actin through its repeat region that contains 8 out of the 11 lysines acetylated in 
cortactin. These residues represent a positive ‘charged patch’ region in deacetylated cortactin, 
which is required for F-actin binding. Accordingly, the charge-neutral hyperacetylated cortactin 
cannot bind F-actin. Only deacetylated cortactin can translocate to the cell periphery upon 
growth factor binding, while an acetylation mimetic mutant that can bind HDAC6, is defective in 
its ability to localize to the leading edge membrane. This mutant was also shown to reduce the 





shown to be downstream of Rac1 activation. These results clearly show that HDAC6 catalytic 
activity is required for cell migration but induces effects on both actin and MT networks. 
In direct contrast the migration of lymphocytes was shown to be independent of HDAC6 
deacetylase activity, requiring only the physical presence of the enzyme (Cabrero et al., 2006; 
Hubbert et al., 2002). This is not surprising when one considers that in vivo motility of cells 
employs vastly different modes of motility for single cells (e.g., fibroblasts and other 
mesenchymal cells) than cells that move in sheets or layers (e.g., epithelial derived cells). 
Fibroblast or epithelial cells moving as part of a monolayer require MT-dependent polarization 
to generate a persistent direction of motility. However, single cells that tend to move more 
rapidly, e.g., leukocytes, lymphocytes or keratinocytes do not depend on intact MTs for their 
motility (Cabrero et al., 2006; Waterman-Storer and Salmon, 1999) and thus, clearly exhibit a 
mode of motility in which cellular polarization is not rate-limiting. It is of interest that in 
fibroblasts it was later shown that the catalytic and the BUZ domain deletion mutants were 
impaired in their ability to bind Hsp90, although they could localize to membrane ruffles 
(Kovacs et al., 2005). Intriguingly, the BUZ domain deletion mutant inhibited cell motility and 
ruffling to a similar extent as the catalytic inactive mutant indicating that deacetylase 
independent functions are also at play in fibroblast motility (Gao et al., 2007). Whether the BUZ 
domain regulates fibroblast motility in a MT-dependent or independent manner is however not 
known. 
HDAC6 also plays an important role in the metastatic potential of many cancers. 
HDAC6, the product of an estrogen-regulated gene (Saji et al., 2005), was shown to directly 
interact with the estrogen receptor alpha (ERα) (Azuma et al., 2009). A membrane-targeted ERα 





local tubulin deacetylation. This in turn increased migration and proliferation of MCF-7 cells, a 
breast cancer cell line. This result is significant as HDAC6 upregulation in breast cancer is 
known to be an indicator of poor patient prognosis. HDAC6 activity is also required for the 
TGFβ-1 dependent epithelial-mesenchymal transition in many invasive tumors (Shan et al., 
2008). Furthermore, HDAC6 interacts with the breast cancer metastasis suppressor 1, BRMS1, 
the destabilization of which by deacetylated Hsp90 was shown to decrease its tumor suppressor 
functions (Hurst et al., 2006).  
HDAC6 activity may also play a role in hypoxia-induced angiogenesis, as HDAC6 
interacts with and stabilizes Hypoxia-Inducible Factor 1α, HIF1α, which mediates transcription 
of genes needed for angiogenesis, in response to hypoxic conditions (Qian et al., 2006). In 
support of this idea, recent studies showed that HDAC6 activity promotes MT-dependent cell 
migration and angiogenesis in endothelial cells (Birdsey et al., 2012; Li et al., 2011a), and that 
this occurs through the MT plus-end binding protein, EB1 (Li et al., 2011a). On the other hand, 
deacetylation of cortactin by HDAC6 has also been reported to contribute to angiogenesis and 
cancer cell migration, thus implying a role for actin in these processes (Kaluza et al., 2011; 
Tsunoda et al., 2011). 
Thus, multiple mechanisms govern the complex role of HDAC6 in modulating cell 
migration. As outlined above, a majority of substrates and interacting proteins are directly 
involved in regulating motility. Through the specific interactions derived here, HDAC6 not only 
alters directly the properties of both MTs and actin networks, but it also functions through 
deacetylase-dependent and -independent means of regulating cell motility. 
 





The ubiquitin-aggresome pathway, a hallmark of neurodegenerative diseases, is triggered 
by the aggregation of ubiquitinated proteins in excess of the cell’s degradation capacity upon 
cellular stress (Boyault et al., 2006; Kawaguchi et al., 2003). HDAC6 is a required component of 
the ubiquitin-aggresome pathway. For example, Kawaguchi et al. showed that HDAC6 binds 
both dynein and polyubiquitinated proteins to mediate the MT-dependent transport of cytotoxic 
ubiquitinated aggregates to the aggresome (2003). The linking of polyubiquitinated cargo to the 
dynein motor by HDAC6 is essential for cell survival, as HDAC6 knockdown cells with 
increased accumulations of polyubiquitinated and misfolded proteins are prone to apoptosis. 
Moreover, both the deacetylase-independent ubiquitin-binding BUZ domain and the HDAC6 
deacetylase activity are required for this dynein-mediated clearing of cytotoxic proteins. 
HDAC6 function in the ubiquitin-aggresome pathway can be negatively regulated by its 
interactions with several proteins. In normal, unstressed cells, the chaperone protein, p97/VCP, 
and the phospholipase PLAP2 bind and sequester HDAC6 and mediate release of ubiquitinated 
proteins from the complex (Boyault et al., 2006; Seigneurin-Berny et al., 2001). The subsequent 
proteasomal degradation of these ubiquitinated proteins prevents aggresome formation. In fact, 
HDAC6, in complex with Hsp90 can also sequester the transcription factor HSF1 (Whitesell and 
Lindquist, 2005) which is required to induce a heat shock response in stressed cells (Boyault et 
al., 2006). Ubiquitin binding disrupts this complex, releasing HDAC6 to its aggresome function, 
and allowing HSF1 to translocate to the nucleus to induce transcription of heat shock genes. 
p97/VCP, however, may also disrupt aggresome formation by disorganizing the MT network. 
HDAC6 has not been shown to deacetylate Hsp90 within the Hsp90/HSF1 complex. 
However, HDAC6 deacetylation of Hsp90 was previously reported to regulate its chaperone 





dissociation from its co-chaperone, p23, thus impairing its ability to chaperone and cause 
maturation of glucocorticoid receptor, ultimately decreasing glucocorticoid receptor function 
(Kovacs et al., 2005). Via a similar mechanism, HDAC6 inhibition also affected Hsp90 
chaperone function on several oncogenic client proteins, such as Bcr-Abl and Akt (Bali et al., 
2005). 
TPPP/p25 and tau are two negative neuronal regulators of HDAC6 that work by directly 
inhibiting HDAC6 deacetylase activity and thus allowing increased aggresome formation 
(Guthrie and Kraemer, 2011; Perez et al., 2009; Tokesi et al., 2010). The TPPP/p25 interaction 
with HDAC6 could be prevented by tubulin thus it is unlikely that TPPP/p25 interacts with 
HDAC6 in the cytoplasm, where tubulin is abundant. However, TPPP/p25 has been shown to be 
involved in Parkinson’s disease, in which it accumulates in Lewy bodies, where HDAC6 
inhibition could occur. Though the pharmacological inhibition of HDAC6 by TSA or tubacin did 
not disrupt the tau-HDAC6 interaction it was shown to modify tau phosphorylation (Ding et al., 
2008). The hyper-phosphorylation of tau disrupts its MT binding and promotes its own 
aggregation. 
The interaction of parkin with HDAC6 and MTs also regulates the ubiquitin-aggresome 
pathway. Parkin is an E3 ubiquitin ligase that is involved in Lewy body formation, an aggresome 
like structure, in Parkinson’s disease (Jiang et al., 2008). The translocation of parkin to the 
centrosome upon proteasome inhibition (Kawaguchi et al., 2003; Kopito, 2000), was shown to be 
HDAC6- and dynein-dependent (Jiang et al., 2008). The transport of parkin was found to be 
important in its function for further ubiquitination and processing of the proteins undergoing 
trafficking to the aggresome. The localization of parkin was found to be dependent on both MT 





Consistent with the findings of Kawaguchi et al. (2003), the MT-dependent bidirectional 
movements of parkin also require HDAC6 deacetylase activity (Jiang et al., 2008). Cortactin has 
been shown to be involved in HDAC6- and parkin-dependent clearing of ubiquitinated 
mitochondria (Lee et al., 2010) indicating that aggresome formation is also dependent on actin. 
HDAC6 deacetylase activity and its ubiquitin-binding property regulate another 
important function in response to cellular stress. Stress granules are involved in the reversible 
suppression of protein translation to help avoid stress-induced cell death. HDAC6 was shown to 
bind ubiquitinated G3BP, a stress granule component, to mediate the dynein-dependent 
translocation of these proteins to stress granules (Kwon et al., 2007). Pharmacological inhibition 
or genetic ablation of HDAC6 abrogated the formation of stress granules, as did MT and dynein 
inhibitors. Thus, this process, which is directly parallel to aggresome formation, also requires 
both the deacetylase activity and ubiquitin-binding functions of HDAC6.  
In addition, in response to DNA damage, HDAC6 blocks cell cycle progression and 
cytokinesis via a mechanism dependent on MTs and CYLD (Wickstrom et al., 2010). 
Interestingly, HDAC6 has been shown to localize to mitotic MT structures including the spindle, 
centrosomes and midbody (Zhang et al., 2003b). Since SIRT2 deacetylates tubulin during 
mitosis, it regulates the levels of Ac MTs even in HDAC6 null cells resulting in normal spindle 
formation and dynamics. 
HDAC6 is also involved in the regulation of immune function in cells (Serrador et al., 
2004). Formation of a proper immune synapse requires transient deacetylation of MTs upon 
initial contact with the target cell, as well as an increase in Ac MTs at later stages of synapse 
formation. HDAC6 overexpression, but not that of a catalytically inactive mutant, disorganized 





overexpression disrupted MTOC reorientation and IL-2 production. These data show a role for 
Ac MTs in immune synapse formation and MTOC reorientation, though the mechanism for this 
is not yet understood. Several viruses have also been shown to manipulate HDAC6 activity 
during infection (Valenzuela-Fernandez et al., 2008). Induction of MT acetylation near the cell 
cortex at the viral contact site seems to be a paradigm for viral infection in HIV and Herpes 
viruses. Ac MTs at cortical sites may stabilize viral contacts. Alternatively, decreased HDAC6 
activity/increased acetylation may enhance MT-based translocation to the nucleus, as some 
viruses seem to prefer transport on Ac MTs. However, other viruses appear to require 
deacetylated MTs. HDAC6 has recently been shown to deacetylate the HIV transcriptional 
activator, Tat (Huo et al., 2011). 
HDAC6 has been implicated in several other biological processes, including myogenesis, 
osteoclast maturation, and ciliogenesis. During myogenesis, dysferlin, a transmembrane protein 
that binds HDAC6 and α-tubulin and regulates the deacetylation reaction, links HDAC6 function 
to a progression of myogenesis (Di Fulvio et al., 2011). Elaboration of an oriented, acetylated 
array of MTs occurs before myoblast fusion (Gundersen et al., 1989). Generation of a stable, 
posttranslationally modified microtubule array is an early event in myogenic differentiation; 
these results argue that this array may be necessary for myogenic differentiation.  Inhibition of 
HDAC6 by tubastatinA, a tubacin congener, early in myogenic differentiation impaired myotube 
fusion and concomitantly increased nocodazole and cold-resistant Ac MTs that were not oriented 
intracellularly (Di Fulvio et al., 2011). We previously showed that precluding the elaboration of 
detyrosinated  (Glu) MTs abrogated myotube formation and blocked the synthesis and/or 





dysregulation of HDAC6 and MT acetylation early in the myogenic program is sufficient to 
disrupt morphological muscle differentiation. 
HDAC6 is involved in bone development; stimulation of HDAC6 by mDia2 prevents 
osteoclast maturation, by disrupting formation of the podosome belt that is dependent on Ac 
MTs, thus leading to bone defects (Destaing et al., 2005). In contrast, HDAC6 null mice showed 
slightly increased bone density (Zhang et al., 2008). Finally, HDAC6 is also involved in 
ciliogenesis through BBSome function. BBSomes are protein complexes whose loss or 
malfunction causes Bardet-Biedl syndrome; the BBSome interacting protein, BBIP10, also 
interacts with HDAC6 and regulates MT acetylation. BBIP10’s role is unique, as other subunits 
of the BBSome are principally involved in the generation and function of the primary cilium 
(Loktev et al., 2008). Independent of its HDAC6 interaction, BBIP10 also binds directly to MTs, 
enhancing their stability and therefore further enhancing MT acetylation. BBIP10 is also thought 
to play a role in centrosome cohesion, though whether this is a result of binding to centrosomal 
MTs is unknown. The significance of these results to ciliogenesis or other functions remains to 




Though a role of MT acetylation is implicated in cell migration (Haggarty et al., 2003; 
Hubbert et al., 2002; Lafarga et al., 2012; Tran et al., 2007), the underlying mechanisms by 
which HDAC6-mediated deacetylation of tubulin modulates directional cell motility have not 





regulates polarization of subcellular organelles and intracellular transport towards the leading 





















































HDAC6 activity is required for polarization of cells and  






The deacetylase HDAC6 is involved in chemotactic or wound-healing motility of 
fibroblastic, epithelial, and endothelial cells (Birdsey et al., 2012; Hubbert et al., 2002; Lafarga et 
al., 2012), all of which require an intact MT cytoskeleton for cell migration and polarization 
(Aldana-Masangkay and Sakamoto, 2011; Gotlieb et al., 1983; Valenzuela-Fernandez et al., 
2008). Furthermore, HDAC6, which is upregulated in many cancers, has been linked to the 
metastatic potential of tumors (Aldana-Masangkay and Sakamoto, 2011; Saji et al., 2005). In 
previous studies, fibroblasts subjected to pharmacological or genetic treatments that either 
increase (Hubbert et al., 2002) or decrease (Haggarty et al., 2003; Tran et al., 2007) the activity 
of HDAC6 showed a corresponding increase or decrease in cell motility in a chemotactic 
invasion assay, thus establishing the importance of  HDAC6 deacetylase activity in motile cells. 
Strikingly, unlike for other HDACs, alpha-tubulin was found to be the most abundant HDAC6 
substrate (Hubbert et al., 2002; Matsuyama et al., 2002; Zhang et al., 2003b). However, despite 
an evident functional link between HDAC6, MTs and cell motility, the mechanism(s) by which 
α-tubulin deacetylation by HDAC6 impacts on directional migration remain unclear. 
MTs are not required for the mechanics of cell crawling, which is dependent upon the 
actin microfilament system. Instead, ablation experiments have shown that MTs are critical for 
polarizing cellular contents and intracellular trafficking, thereby generating and maintaining a 
leading edge lamellipodia to provide directional persistence of motility (Bershadsky et al., 1991; 
Glasgow and Daniele, 1994; Wittmann and Waterman-Storer, 2001). MT-dependent cell 
polarization has been studied most intensively in the wound-healing model of motility (reviewed 
by Noritake et al., 2005), in which cells migrate to close a wound that has been scratched into a 





An initial step in polarizing fibroblasts for wound-healing motility is the selective 
stabilization and subsequent posttranslational modification by detyrosination (Gundersen and 
Bulinski, 1988) and acetylation (Akhmanova et al., 2001) of a subset of their MTs whose distal 
(plus) ends are closest to the wound edge. Reorientation of the MT-organizing center (MTOC) 
and Golgi apparatus towards the wound-edge (Kupfer et al., 1982) is known to be important for 
polarized membrane trafficking towards the leading edge (Bergmann et al., 1983) and the stable, 
modified MT array was proposed to provide a template for polarization of these organelles 
(Bulinski and Gundersen, 1991; Kirschner and Mitchison, 1986). These classic experiments 
raised two questions about how MT arrays function to polarize wound-edge cell components: 
First, how does a subset of MTs that faces the wound-edge become stabilized? Second, how does 
the post-translational modification of the newly stabilized MT subset alter its functions, e.g., 
what role do posttranslationally modified MTs play in polarizing MT-dependent transport of 
organelles and plasma membrane vesicles? 
A wealth of information now effectively answers the first question: Stabilization of MTs 
facing the wound-edge is mediated by capping of their distal (plus) ends (Infante et al., 2000), 
via one of two distinct molecular mechanisms. Akhmanova et al. (2001) showed that two  +TIPs, 
that is, proteins that bind to the plus ends of growing MTs, attach as a CLIP170-CLASP complex 
that then docks in the cell cortex with an LL5β and ELKS receptor complex (Lansbergen et al., 
2006). The second mechanism, discovered concurrently, consists of RhoA stabilization through 
mDia (Palazzo et al., 2001a), with binding and stabilization via the additional +TIPs, EB1 and 
APC (Wen et al., 2004). Since both pathways are regulated analogously by the kinase, GSK3β 





et al., 2010) and mDia (Bershadsky et al., 2006; Destaing et al., 2005) it is possible that HDAC6 
protein and perhaps its deacetylation activity could modulate wound-edge MT stabilization.  
The second question, that is, how the post-translational modification state of the wound-
edge MT subset alters its functions, has not been as well-explored. One means by which 
detyrosinated and/or acetylated tubulin subunits along the length of stable MTs could signal the 
stability of that MT or the location of its plus end is for these modified subunits to modulate MT-
dependent polarization and transport. For example, MTOC reorientation, independent of MT 
stabilization (Palazzo et al., 2001b), occurs by a capture of MT plus ends by p150glued, which is 
a +TIP and a dynein receptor (Vaughan, 2005). p150glued then docks to dynein anchored in the 
cortex at the leading edge of motile cells (Dujardin et al., 2003; Gomes et al., 2005). Moreover, 
Golgi reorientation occurs via one or a combination of several mechanisms. Golgi polarization 
could occur either through its close association with the MTOC (Kupfer et al., 1982), its 
preferential recognition of posttranslationally modified MT arrays (Skoufias et al., 1990; 
Thyberg and Moskalewski, 1993) or its nucleation of MTs (Efimov et al., 2007), especially 
stable MTs destined for acetylation or detyrosination (Chabin-Brion et al., 2001). Thus, 
differential recognition of posttranslationally modified MTs by MT-associated proteins (MAPs) 
and MT motor proteins might be sufficient to polarize cellular contents during directional 
migration. There is suggestive evidence for this hypothesis. For example, intracellular transport 
was shown to be inhibited in Taxol-treated cells (Hamm-Alvarez et al., 1994; Hamm-Alvarez et 
al., 1993). Taxol increases both the cellular density of MT polymers and the content of 
posttranslationally modified acetylated and detyrosinated subunits within MTs (Gundersen et al., 
1987). In vitro biochemical studies of the kinesin-MT interaction showed modestly increased 





as compared to tyrosinated tubulin (Liao and Gundersen, 1998). Similarly, microinjection of 
IgGs specific for detyrosinated tubulin inhibit kinesin-mediated anterograde transport of kinesin 
cargoes, suggesting a preference of kinesin for the population of MTs that is enhanced in 
detyrosinated tubulin (Gurland and Gundersen, 1995; Kreitzer et al., 1999; Lin et al., 2002).  
MT acetylation, like detyrosination, has also been reported to increase intracellular 
trafficking. Using MTs from ciliary axonemes or chemically acetylated mammalian brain MTs, 
kinesin-1 and dynein were found to bind acetylated MTs with higher in vitro binding affinities 
(Dompierre et al., 2007; Reed et al., 2006). In vivo, hyperacetylation of MTs in HDAC6-
inhibited cells increased polarized kinesin-1-based transport of JIP1 and increased bidirectional 
transport of BDNF vesicles in neuronal cells (Dompierre et al., 2007; Reed et al., 2006).  
However, since both of these studies used heterologous MT preparations and HDAC6 inhibitors, 
they are hard to extrapolate to the situation in motile, genetically null fibroblasts. In that system, 
altered MT function by HDAC6 inhibition or deletion was linked to decreased focal adhesion 
turnover; an effect mediated by moderately stabilized MTs (Tran et al., 2007).  
Recently, GRK2, a G-protein coupled receptor, was shown to contribute to regulation of 
HDAC6-mediated modulation of MT acetylation, in turn enhancing directional migration of 
fibroblasts and epithelial cells (Lafarga et al., 2012). GRK2 and HDAC6 were colocalized at the 
leading edge of migrating cells, and inhibition of HDAC6 by GRK2 mutants impaired cell 
migration and protrusive activity. Furthermore, a tight regulation of acetylated MT levels by the 
GRK2-HDAC6 interaction was found to be important for both early and late phases in spreading 
cells. Cortactin acetylation was unaltered by HDAC6 activity in these cells, but a scenario in 
which altered HDAC6 deacetylation of Hsp90 regulated motility through regulation of the actin 





Thus, based upon the fact that both MT-dependent cellular polarization and HDAC6 
deacetylase activity are important for directionally migrating cells, and that tubulin is a major 
substrate of HDAC6, we hypothesized that HDAC6 activity towards tubulin/MTs is required for 
efficient polarization of motile cells. However, although hyper-acetylated MTs have been 
implicated in decreasing directional motility of HDAC6-inhibited fibroblasts, other in vivo 
deacetylation substrates of HDAC6 may also function in cell migration; for example, Hsp90 
(Bali et al., 2005; Kovacs et al., 2005) and/or cortactin (Zhang et al., 2007). Indeed, both 
cortactin (Zhang et al., 2007) and Hsp90 (Gao et al., 2007) were shown to affect cell motility via 
regulation of actin-dependent processes. Therefore, delineating the role of HDAC6 in directional 
motility warrants consideration of the acetylation state and role(s) in motility of all of HDAC6 









Loss of HDAC6 and its activity decrease directional migration. 
To test whether the loss of HDAC6 impacts directional migration of fibroblasts, we 
compared the wound-healing motility of mouse embryo fibroblasts (MEFs) genetically null for 
HDAC6 (HDAC6 KO MEFs) prepared from viable HDAC6 (-/y) mice (Zhang et al., 2008), to 
wild-type fibroblasts (WT MEFs) prepared from HDAC6 (+/+) littermates. HDAC6 KO MEFs 
showed greatly decreased ability to migrate into an experimental wound; Fig. 1A shows that 
speed of wound closure was reduced by more than 60%, compared to WT MEFs. We 
corroborated these results with live cells; we examined motility of HDAC6 WT and KO MEFs 
by live imaging using phase microscopy (see supplementary movies). These wound-healing 
movies were consistent with results from fixed-cell assays; both clearly show that HDAC6 KO 
MEFs are impaired in their directional migration into the wound, showing instead more random 
migration than did WT MEFs. However, membrane ruffling at the leading edge appeared similar 
in HDAC6 WT and KO MEFs, suggesting that actin-dependent processes in migrating cells are 
not altered by the loss of HDAC6. 
As predicted, HDAC6 KO MEFs showed a level of acetylated (Ac) tubulin much 
increased over WT MEFs, an even higher  level than that observed in HDAC6 WT MEFs treated 
with TSA, a general Class I and II HDAC inhibitor, for 4 hours (Fig. 1B). Importantly, the level 
of detyrosinated or Glu tubulin, a reporter of MT stabilization (Gundersen et al., 1987) was 
unaffected by loss of HDAC6 activity in both HDAC6 KO and TSA-treated WT MEFs. 
However, both HDAC6 KO and WT MEFs showed a similar capacity to generate Glu tubulin in 
response to Taxol treatment. In contrast, Taxol treatment did not detectably alter the level of Ac 





concentrations (1 M for both) Taxol stabilizes MTs more potently than TSA (Tran et al., 2007), 
and that TSA treatment is amenable to a dissection of the role of microtubule acetylation in 
wound-healing motility, independent of any role of detyrosination.  
Chemotactic  invasion motility of a different cell type, lymphocytes, which like other fast 
moving cells do not require intact MTs or polarization of their contents for their motility 
(Cabrero et al., 2006; Waterman-Storer and Salmon, 1999) is dependent on level, not deacetylase 
activity, of HDAC6 (Cabrero et al., 2006). Accordingly, we compared the wound-healing 
migration of HDAC6 inhibited WT MEFs, which have normal level but reduced activity of 
HDAC6, to KO MEFs which have no HDAC6 protein or activity. As shown in Fig. 1C, treating 
WT MEFs with trichostatin A (TSA), to inhibit all class I and II HDACs, including HDAC6 
(Hubbert et al., 2002; Matsuyama et al., 2002), significantly reduced the rate of wound closure. 
TSA effects were dose-dependent (data not shown), but we used 1 µM TSA in all experiments, 
to maximize the level of hyper-Ac tubulin. In contrast, treatment with sodium butyrate (NaB), to 
inhibit all class I and II HDACs except HDAC6 and HDAC10 (HDAC10 has no  known 
substrates) (Guardiola and Yao, 2002), did not alter wound-healing rate, relative to the control 
(Fig.1C).  
Notably, neither TSA nor NaB changed wound-healing migration rate of HDAC6 KO 
MEFs (Fig. 1C). These data indicate that activities of all other HDACs, except HDAC6, that 
would be inhibited by these drugs are not important for wound-healing migration. Furthermore, 
since enzymatically inactivated HDAC6 can associate with MTs (Haggarty et al., 2003), or 
modulate cellular functions (Cabrero et al., 2006; Zilberman et al., 2009), the fact that results 





deacetylase activity of HDAC6, rather than a structural role of inactive HDAC6, which mediates 
the inhibition of directional motility. 
  
Loss of HDAC6 increases the acetylation of tubulin, but not Hsp90 and cortactin.  
To understand the role of HDAC6 deacetylation activity, it is necessary to determine 
which hyper-Ac substrate proteins might accumulate and affect cell migration. HDAC6 has 
several known substrates; although the best-characterized of these is tubulin (Hubbert et al., 
2002; Matsuyama et al., 2002; Zhang et al., 2003b), other well-known substrates are histones 
(Zhang et al., 2003b), the chaperone protein, Hsp90 (Bali et al., 2005; Kovacs et al., 2005), and 
the actin-binding protein, cortactin (Zhang et al., 2007). In fact, the latter two, Hsp90 (Gao et al., 
2007) and cortactin (Zhang et al., 2007), have both been shown to enhance cell motility by 
modulating actin. We therefore analyzed which HDAC6 substrates, besides tubulin, became 
hyper-acetylated, both under the drug regimens we used to reduce HDAC6 activity in motile 
MEFs and in HDAC6-null fibroblasts. In previous work, we showed that TSA treatment 
substantially increased acetylation of tubulin, as well as histones, but not Hsp90 (Tran et al., 
2007). Here, we used the same Keyhole limpet Ac protein (KLAC) antibody, designed to react 
with all Ac-lysines irrespective of the sequence of the flanking amino acids, to determine which 
HDAC substrate proteins, in addition to tubulin, become hyper-acetylated in MEFs lacking 
HDAC6.  
As shown in Fig. 2, Hsp90 acetylation was not detectably greater in HDAC6 KO than in 
WT MEFs, even when the former were treated with TSA suggesting that Hsp90 is not 
deacetylated exclusively by HDAC6 or other classical HDACs (Fig. 2A). In contrast, tubulin was 





TSA-treated HDAC6 KO MEFs (Fig. 2A), corroborating the identification of HDAC6 as the 
only HDAC that deacetylates tubulin (Matsuyama et al., 2002). Figure 2A also documents that 
hyper-acetylation of histones did not occur in HDAC6 KO cells except when they had been 
treated with TSA. This corroborates results of Zhang et al. (2008); although HDAC6 has 
deacetylation activity towards histones (Zhang et al., 2003b) many other HDACs continue to 
deacetylate histones in the absence of HDAC6.  
Similar to Hsp90 and histones, immune-precipitated cortactin also showed the same 
degree of acetylation in HDAC6 KO MEFs compared to WT MEFs (Fig. 2B). We tested the 
specificity of the KLAC antibody for lysine -amino group acetylation by preabsorbing KLAC 
with N-epsilon-acetyl-L-lysine. Cortactin, is a deacetylation substrate of either HDAC6 or 
SIRT2 (Zhang et al., 2007), so it is important to evaluate its acetylation state in HDAC6 KO 
cells. We therefore performed KLAC antibody-labeled western blots of cortactin IPs, following 
treatment with inhibitors of other deacetylases (Figure 2C). Inhibition of HDAC6 KO MEFs with 
TSA, to block HDACs 1-11, did not change cortactin acetylation level, but inhibition of all the 
sirtuin family of NAD-dependent deacetylases (SIRTs) with sirtinol yielded increased acetylated 
cortactin (Fig. 2C).  This result agrees with the finding that cortactin is a deacetylation substrate 
of either HDAC6 or SIRT2 (Zhang et al., 2007), and further suggests that SIRT2 compensates 
for increased acetylation of at least one HDAC6 substrate in the absence of HDAC6 background. 
Taken together, these results show that tubulin, but not Hsp90, histones, or cortactin, is 
exclusively dependent upon HDAC6 activity for its deacetylation in MEFs. Importantly, these 
data also suggest that in wound-healing of MEFs that lack HDAC6 activity, MTs are hyper-Ac 
and could impact motility, while the other HDAC6 substrate proteins, Hsp90 and cortactin are 






Loss of HDAC6 activity yields abnormal acetylated MT arrays.     
We hypothesized that hyper-acetylation of all cellular MTs precludes formation of a 
polarized array of Ac MTs during directional migration. To test this hypothesis we treated 
wound-edge WT and HDAC6 KO MEFs with vehicle alone (DMSO), with TSA, and with 
tubacin. We examined the distribution of Ac MTs by immunofluorescence with Ac tubulin 
antibody. Tubacin, a small molecule that selectively inhibits HDAC6 increases Ac-tubulin 
without altering Ac-histones (Haggarty et al., 2003), Ac-Hsp90 (Tran et al., 2007) or Ac-
cortactin (Lafarga et al., 2012). Further, tubacin has been shown to be as effective as TSA, in 
blocking chemotactic invasion motility of fibroblasts (Tran et al., 2007). Consistent with our 
prediction, complete ablation of HDAC6 expression through gene knock out, inhibition of all 
HDACs via TSA-treatment, or specific inhibition of tubulin deacetylation by blocking HDAC6 
with tubacin (Figs. 3A and B, Supplementary Fig. 1A, and Supplementary Fig. 2A, respectively), 
all yielded wound-edge cells with hyper-Ac MTs that lacked a polarized array of Ac MTs. 
However, while levels of tubulin hyper-acetylation were greatly increased in TSA-treated 
WT or HDAC6 KO MEFs (Fig. 1B), tubacin treatment, though equivalent in the extent of 
mislocalization of oriented Ac MT arrays (compare Fig. 3A and Supplementary Fig. 1A to 
Supplementary Fig. 2A), was less effective in inducing hyper-acetylation of tubulin (Ac-tubulin 
levels were increased by as much as 67% in TSA treatment; Supplementary Fig. 2B). Treatment 
with Taxol to stabilize all MTs instead of only a polarized subset also mislocalized the Ac MT 
array in a majority of cells (data not shown), even though Taxol treatment did not increase MT 
acetylation level, as detected by western blot (Fig. 1B) or immunofluorescence (data not shown). 





HDAC6 inhibition or depletion disrupts the selective stabilization of the Ac MT subset towards 
the wound-edge. Moreover, Taxol, whose potent stabilization of MTs causes a significant 
increase in Glu tubulin (Gundersen et al., 1987), also mislocalizes the Ac MT subset. However, 
HDAC6 inhibition prevents the polarization of the Ac MT array independent of any major 
effects on MT stabilization (Tran et al., 2007) or detyrosination. 
 
Loss of HDAC6 activity prevents polarization of subcellular organelles.    
We originally proposed that post-translational modification of a subset of MTs functions 
to scaffold reorientation of other organelles (Bulinski and Gundersen, 1991). We next tested this 
hypothesis, asking whether the failure to polarize an Ac MT array affects polarization of each of 
four other subcellular components: 1) the stable MT subset, which is identified by its heightened 
content of Glu tubulin (Gundersen et al., 1987); 2) the MTOC, which rapidly reorients during 
wound-healing motility by a mechanism independent of the reorientation of the stable MT array 
(Palazzo et al., 2001b); 3) the Golgi complex, whose polarization appears to polarize vesicular 
transport and secretion to the leading edge (Bergmann et al., 1983); and 4) the vimentin 
intermediate filament array, whose reorientation towards the leading edge of motile cells requires 
kinesin and a polarized Glu MT subset (Gurland and Gundersen, 1995; Kreitzer et al., 1999). As 
shown in Figs. 4A and 4B, all four organelles examined were mislocalized in HDAC6 KO, as 
compared to WT, MEFs. HDAC6 KO MEFs were affected similarly in organelle reorientation 
(Fig. 4B) and wound-healing motility speed (compare Fig. 4B to Fig. 1A). For example, ablation 
of HDAC6 expression decreased polarization of the Golgi by ~60%; similar to the decrement in 
wound-closure speed. Each of the four organelles we monitored also failed to orient towards the 





WT and KO MEFs (Supplementary Fig. 1B). These data suggest that either inhibition or loss of 
HDAC6 activity inhibits organelle polarization, suggesting that these MT-dependent events may 
result from MT hyperacetylation or failure to orient an Ac MT array towards the leading edge. 
Moreover, failure to polarize cellular contents may be coupled to a decrease in directional 
migration.  
We also tested the effects of treating WT MEFs with the HDAC6-selective inhibitor, 
tubacin (Haggarty et al., 2003). Tubacin treatment yielded a significant disruption in polarization 
of all four organelles examined (Supplementary Fig. 2C). However, the extent of inhibition was 
less than that seen in HDAC6 KO MEFs, or in TSA-treated WT MEFs (compare Figs. 4B, Supp. 
Fig. 1B, and Supp. Fig. 2C). These results are consistent with the fact that, in our hands, tubacin 
yields a lower level of MT hyper-acetylation than does TSA treatment or complete ablation of 
HDAC6, as in HDAC6 KO MEFs (Supplementary Fig. 2B). This and other results show that the 
degree to which organelles fail to reorient in wound-edge cells is always commensurate with 
their degree of MT hyper-acetylation.  
 
Loss of HDAC6 disrupts dynein-mediated cortical attachment of MTs via the +TIP 
p150glued 
Redistribution and accumulation of cortical proteins at the leading edge is an early step in 
the polarization process that reorients the MTOC in response to the monolayer wounding 
stimulus (Dujardin et al., 2003; Lansbergen et al., 2006). The MT +TIP, p150glued, a subunit of 
the dynactin complex, mediates selective capture of MT plus ends by dynein localized in the cell 
cortex at the leading edge of migrating cells (Dujardin et al., 2003). The p150glued-dynactin 





Gomes et al., 2005; Palazzo et al., 2001b), and persistent directional migration (Dujardin et al., 
2003), independent of selective MT stabilization. Moreover, HDAC6 has been shown to directly 
bind the retrograde MT motor dynein (Kawaguchi et al., 2003) and interact with p150glued 
(Hubbert et al., 2002; Kawaguchi et al., 2003). To address the mechanism underlying the defect 
we observed in MTOC positioning in directionally migrating cells, we localized both p150glued 
(Figs. 5A and B) and its cortical docking receptor, dynein (Figs. 5C and D) in WT and HDAC6 
KO MEFs. HDAC6 KO MEFs showed greatly reduced p150glued localization on MT plus ends 
(~ 45%, Figs. 5A and B), while they showed similarly reduced cortical dynein at the leading 
edge cell cortex (also ~ 45%, Figs. 5C and D). While the few small and dim cortical patches of 
dynein in KO cells (Fig 5C) almost entirely coincided with MTs converged at the leading edge 
(data not shown), the converse was not true; sites at which MT distal ends converged in the 
lamellipodia showed markedly reduced cortical dynein (Fig. 5C and D) in HDAC6 KO MEFs as 
compared to their WT counterparts. These data suggest that loss of HDAC6 decreases MT-cortex 
interactions interfering with the p150glued-dynein pathway. Not only do these results provide a 
plausible mechanism for the MTOC reorientation defect, they also suggest that loss of HDAC6 
might impact on other dynein pathways. 
 
Loss of HDAC6 activity decreases bidirectional Golgi vesicle transport.         
Polarization of membrane trafficking towards the leading edge mediates polarized 
membrane renewal during directional migration (Bergmann et al., 1983). Moreover, bidirectional 
transport mediated by kinesin-1 and dynein was reported to occur preferentially on Ac MTs and 
to increase on hyper-acetylated MTs (Dompierre et al., 2007; Reed et al., 2006). The MT 





(Vaughan, 2005) and also serves as a processivity factor for dynein motility (King and Schroer, 
2000). From our result that p150glued was decreased in binding to MT ends in HDAC6 KO, 
compared to WT MEFs, and that HDAC6 directly binds dynein (Kawaguchi et al., 2003) we 
hypothesized that MT-dependent dynein transport is impaired by loss of HDAC6. To test this 
hypothesis, we analyzed Golgi vesicle trafficking, known to be mediated by dynein retrograde 
motility (Vaughan, 2005), by live-imaging of Golgi vesicles fluorescently-labeled with BODIPY 
ceramide, a trans-Golgi lipid marker that labels Golgi vesicles that undergo bidirectional 
transport (Klausner et al., 1992). 
While steady-state Golgi structure did not appear to be greatly altered (see Fig. 7A), a 
marked change was observed in the proportion of the total vesicles that showed motility during 
the 5-minute recordings: the percentage of motile Golgi vesicles was reduced by ~50% in 
HDAC6 KO, compared to WT MEFs (Fig. 6A). Quantification of vesicle motility from time-
lapse images revealed significant but modest inhibition of vesicle trafficking, also in agreement 
with our hypothesis. In fact, quantification of vesicle motility parameters in HDAC6 KO MEFs 
showed that all vesicle motility parameters measured, except for run time, were significantly 
decreased in retrograde or dynein-mediated transport (Fig. 6B). Surprisingly, a similar decrement 
in all vesicle motility parameters was also measured in anterograde or kinesin-based MT 
transport of Golgi vesicles (Fig. 6B).  
Quantification of Golgi vesicle transport in wound-edge migrating HDAC6 KO MEFs 
gave parallel reductions (see supplementary movies, data not shown). Moreover, TSA-treated L6 
myoblast cells we examined previously showed a similar inhibition in bidirectional Golgi vesicle 
transport as compared to the DMSO treated and NaB controls (data not shown). These data 





in vivo. However, from these experiments we cannot determine whether parameters of MT-
dependent kinesin-based transport are inhibited directly by interference with kinesin or indirectly 
by decreased dynein-mediated transport or stalling of dynein-cargo complexes on MTs. 
 
Loss of HDAC6 inhibits both dynein- and kinesin-mediated transport processes. 
From the bidirectional inhibition of MT-based Golgi vesicle transport in HDAC KO 
cells, we hypothesized that loss of HDAC6 activity manifests direct effects on dynein- and/or 
kinesin-based transport along MTs. To test whether one or both motors is directly inhibited we 
investigated two canonical dynein- and kinesin-specific intracellular transport events.  
We first analyzed dynein-mediated retrograde movement of Golgi elements as they 
clustered and reformed during recovery from treatment with brefeldin A (BFA) (Bulinski et al., 
1997; Burkhardt et al., 1997). BFA induces a MT- and kinesin-dependent (Feiguin et al., 1994; 
Lippincott-Schwartz et al., 1995) redistribution of the Golgi into the peripheral ER, completely 
dispersing the Golgi apparatus into distinct peripheral puncta (Klausner et al., 1992; Lippincott-
Schwartz et al., 1989).  
Analysis of Golgi clustering, performed by immunofluorescence with Golgi antibody, at 
steady-state in WT and HDAC6 KO MEFs (Fig. 7A) showed that although most cells of both 
types clustered around the periphery of the nucleus, a significant proportion of HDAC6 KO 
MEFs exhibited Golgi staining along a greater circumference of the nucleus, rather than a tight 
clustering along one side of the nuclear periphery (Fig. 7A). A brief treatment with BFA 
dispersed the Golgi in both WT and HDAC6 KO and MEFs; the less pronounced dispersal in 
HDAC6 KO MEFs suggested an inhibition of the kinesin motor responsible for transporting the 





Immunofluorescence and quantification during recovery from BFA treatment showed inhibited 
Golgi re-clustering in the HDAC6 KO MEFs (Figs. 7A, B). For example, clustered Golgi were 
again evident in many WT MEFs 15 minutes after BFA release and in a significant majority of 
cells at 45 minutes (Fig. 7B). In contrast some Golgi had not yet re-clustered even at 3 hours 
after BFA release in HDAC6 KO MEFs (Fig. 7B). These data confirm and extend Golgi vesicle 
motility data (Fig. 6), showing that MT-dependent dynein-based vesicular transport is inhibited 
by genetic ablation of HDAC6, while suggesting that kinesin-dependent vesicular transport may 
also be affected in our system. 
To determine whether kinesin-mediated transport is altered, we next assayed transport of 
canonical kinesin cargoes, the mitochondria. Mitochondrial distribution and movement in axons 
has been shown to be dependent on kinesin-1 (Chen et al., 2010; Hollenbeck and Saxton, 2005). 
We tested kinesin-based transport directly in two ways: Initially we examined distribution of 
mitochondria at steady-state in sparse and wound -edge WT and HDAC6 KO MEFs. No 
difference in mitochondrial distribution was measured when we calculated the degree to which 
mitochondria spread towards cell edges (mitochondrial spread area was calculated as a 
proportion of total spread area of MEFs; see Materials & Methods) in sparse cells at steady-state 
(data not shown). However, the quantification of both the mitochondrial area spread towards the 
leading edge (Supplementary Fig. 3) and the extent of the polarization of this organelle towards 
the leading edge which was similar to the extent  polarization of other organelles examined in 
Fig. 4B (data not shown) showed a significant decrease in wound-edge HDAC6 KO MEFs.  
We also hypothesized that mitochondrial kinesin-based anterograde trafficking is directly 
inhibited by loss of HDAC6. To test this, we quantified mitochondrial spread area over time in 





accumulate focal adhesions that turn over slowly (Tran et al., 2007, also see Supp. Fig. 4). 
Accordingly, we quantified mitochondrial area as a proportion of total cell area, to compensate 
for inherent cell size differences during spreading. We also confined our measurements to early 
times during spreading (0-20 minutes) because at these times the HDAC6 KO and WT MEFs are 
similar in size, and also, mitochondria show net movement only in the anterograde direction that 
would be attributable to kinesin. Fig. 7C shows that consistent with our hypothesis, we observed 
a significant inhibition of mitochondrial transport at early time points in the cell spreading 
process. Kinesin-based mitochondrial transport may also be altered when cells are more 
completely spread, but the interpretation of these data is confounded by the increased surface 
area of HDAC6 KO MEFs.  Thus, we confined our analysis to the initial 20 minutes of spreading 
which show that anterograde mitochondrial movement, a canonical kinesin cargo, was 
specifically and independently inhibited in the absence of HDAC6 protein. 
 
Re-expression of HDAC6 or non-acetylatable tubulin rescues Golgi vesicle motility. 
Re-expression of full-length HDAC6 in HDAC6 KO MEFs was technically challenging 
in wound-edge cells; the low efficiency of transfection precluded qualitative and quantitative 
analysis of directional migration. Therefore, we used the single-cell assay of Golgi-vesicle 
transport, as it is amenable to testing the effects of HDAC6 re-expression. We quantified 
bidirectional vesicle motility in HDAC6 KO MEFs transfected with HDAC6 plus GFP, 
transfecting GFP alone as a control. HDAC6 KO cells re-expressing HDAC6 showed rescued 
Golgi vesicle motility parameters in both directions (compare Fig. 8A to Fig. 6B) showing 
irrefutably that the alteration of MT-dependent bidirectional vesicular transport in HDAC6 KO 





Finally, since a loss in HDAC6 activity results in hyper-Ac MTs, we tested whether a 
prevention of MT hyper-acetylation prevents the MT-dependent defects in intracellular transport 
caused by HDAC6 inhibition or loss. To create HDAC6 KO MEFs in which MTs are not highly 
acetylated, we expressed GFP plus K40R-FLAG-α-tubulin into sparse HDAC6 KO MEFs; we 
also expressed GFP plus WT-FLAG--tubulin and GFP alone, as controls. K40R is a non-
acetylatable tubulin mutant, whose arginine mutation prevents the acetylation that normally 
occurs at lysine 40 of -tubulin. We cloned the K40R into a FLAG-tagged--tubulin rather than 
into GFP--tubulin as is commonly used (Creppe et al., 2009; Gao et al., 2010) as we previously 
determined that GFP--tubulin is poorly acetylated, if at all, in vivo, possibly because of the 
bulky, N-terminal GFP tag (Weil, Marmo, and Bulinski, data not shown).  
We subjected HDAC6 KO MEFs expressing each of these constructs to fluorescent 
labeling to examine effects on vesicle motility. Because these experiments present significant 
technical obstacles, we used only the most robust assay of  Golgi vesicle motility, that is, a 
quantification of the proportion of motile vesicles in HDAC6 KO MEFs (an ~50% inhibition as 
seen in Fig. 6A). Quantification of the proportion of motile vesicles in cells transfected with each 
of the tubulin constructs showed that both WT and K40R tubulins equivalently rescued the 
defect in Golgi vesicle motility (Fig 8B).  This result clearly demonstrates that a MT-based 
mechanism is responsible for inhibited bidirectional intracellular trafficking in HDAC6 KO cells. 
However, it is somewhat surprising that the wild-type -tubulin achieved as effective a rescue as 
did the K40R mutant. We cannot conclude from these data whether some overall increase in -
tubulin, rather than a modulation of the acetylation state of lysine 40 is responsible for impacting 












































Figure 1.  Loss of HDAC6 activity decreases directional wound-healing migration. 
Quantification of wound-healing velocities of A) DMEM and C) drug-treated WT and 
HDAC6 KO MEFs. Scratch wounds were made in fibroblast monolayers and the rate of wound 
closure was quantified from coverslips fixed at regular time intervals between 0 and 10 hours 
(see Materials and Methods for details). The indicated drugs, DMSO, 1 µM TSA and 10mM 
NaB were added to the cultures at the time of wounding and maintained for the duration of 
wound-healing migration, i.e., for a total of 10 hours. In A) and C), migration velocities are 
represented as percent of control, i.e., WT MEFS and DMSO-treated WT MEFs, respectively. 
Asterisks indicate significant differences (p<0.05) from controls.  B) Western blot analysis of 
drug-treated WT and HDAC6 KO MEFs, blots were probed with antibodies against Ac, Glu and 
total tubulin (β-tubulin used to label total tubulin as a loading control). Extracts were made after 




















Figure 2.  HDAC6 deacetylates tubulin, but not Hsp90 or cortactin.   
Acetylation level of HDAC6 motility-related substrates from WT and HDAC6 KO 
MEFs. A) Lysates of WT and HDAC6 KO MEFs, or HDAC6 KO MEFs treated with TSA (1 
µM, 4 hours) were probed for Ac proteins, using KLAC antibody (see Materials & Methods for 
details). Ac-Hsp90, -tubulin, and –histones are indicated.  Total tubulin (stained with β-tubulin 
antibody) was used as a loading control.  B), C) Lysates from MEFs treated as indicated for 5 
hours were immunoprecipitated with anti-cortactin antibody, and Ac-cortactin level was 
detected in each, via KLAC antibody. Blots were also probed with KLAC antibody that had 
been pre-incubated with N-epsilon-acetyl-L-lysine (N-e-Ac-L-K). Anti-cortactin antibody was 

















Figure 3.  Loss of HDAC6 shows hyper-acetylation of all cellular MTs and loss of a 
polarized array of Ac MT array.   
A) Immunofluorescence and B) Quantification of polarized Ac MT arrays in wound-edge 
WT and HDAC6 KO MEFs.  Cells were wounded, treated as indicated and allowed to polarize 
for 5 hours before they were fixed and immunolabeled with antibodies against Ac and total 
















Figure 4. Loss of HDAC6 mislocalizes cellular organelles.  
A) Micrographs and B) quantification of the polarization of cellular organelles in WT and 
HDAC6 KO MEFs at the wound edge. Cells were wounded and allowed to polarize for 5 hours 
before fixation and immunolabeling. In A) antibody against Glu tubulin was used to detect 
stable, Glu MTs and MTOCs, and Golgi and vimentin antibodies were used to localize these 
cellular organelles. Quantification was performed by dividing cells into 4 quadrants and scoring 
the number of cells with oriented organelles, i.e., organelles found in the leading edge quadrant. 
Green circles (    ) indicate polarized cells, red cross-hatched circles (    ) indicate cells with 
mislocalized organelles (see Materials and Methods for details).  MTOCs are indicated by white 
arrows.  Wound edges are indicated by black arrows. Bar, 10 µm. In B) at least 200 cells were 
scored per experimental condition in each of three experiments. Asterisks indicate significance 























Figure 5. Loss of HDAC6 inhibits localization of p150glued and dynein to MT plus-ends 
and the leading edge cortex.  
A) Micrographs and B) quantification (see Materials and Methods) of p150glued 
localization on MT plus ends in sparse WT and HDAC6 KO MEFs labeled with p150glued and 
α-tubulin antibodies. Bar, 10 µm.  C) Micrographs and D) quantification of leading-edge 
localization of cortical dynein in WT and HDAC6 KO MEFs. C) MEF monolayers were 
wounded and allowed to polarize for 5 hours before they were fixed and immunolabeled with 
antibodies against dynein intermediate chain (DIC) and α-tubulin. White arrows indicate 
cortical DIC-positive leading edge patches in WT MEFs where MTs were observed to converge. 
Wound edges are indicated by black arrows. Bar, 10 µm. D) Asterisks indicate significant 














Figure 6. Loss of HDAC6 inhibits bidirectional transport of Golgi vesicles.  
Quantification of A) proportion of motile Golgi vesicles and B) Golgi vesicle motility 
parameters in retrograde and anterograde directions in WT and HDAC6 KO MEFs, (see 
Materials and Methods for details). Only vesicles moving at speeds > 0.1 µm/second were 






















Figure 7. Loss of HDAC6 inhibits dynein and kinesin-mediated microtubule-based 
transport.  
A) Micrographs and B) quantification (see Materials and Methods) of treatment and 
recovery from BFA treated WT and HDAC6 KO MEFs. A) Cells were treated with BFA for 45 
minutes (top panel) and allowed to recover (bottom panel) as indicated, fixed and 
immunolabeled with Golgi antibody. B) BFA Recovery curve (left panel); linear portion of 
recovery curve (right panel) displays rate of recoveries from BFA release. C) Quantification (see 
Materials and Methods) of mitochondrial area in spreading cells as relative to total cell area in 
















Figure 8. Re-expression of HDAC6 or non-acetylatable or WT tubulin rescues Golgi vesicle 
transport.  
Quantification of A) Golgi vesicle motility parameters in retrograde and anterograde 
directions in WT and HDAC6 KO, and GFP- or GFP- and HDAC6- transfected HDAC6 KO 
MEFs, and B) proportion of motile Golgi vesicles in HDAC6 KO MEFs that were either 
transfected with GFP alone or GFP and 3X-FLAG-WT α-tubulin or GFP and 3X-FLAG-K40R. 
Only vesicles moving at speeds > 0.1 µm/second were considered motile. Asterisks indicate 





































































Supplementary Figure 1. TSA-treated WT and HDAC6 KO MEFs exhibit similarly 
inhibited polarization of Ac MT arrays and cellular organelles. 
A) Polarization of Ac MT arrays and B) organelle polarization were quantified in both 
drug-treated WT and HDAC6 KO MEFs. The drugs indicated were added to the cultures at the 
time of wounding.  In A) and B), cells were fixed 5 hours after wounding and immunolabeled 
with Ac tubulin antibody in A) and Glu tubulin antibody (to detect stable, Glu MTs and 
MTOCs), and Golgi and vimentin antibodies in B). In A) and B) at least 200 cells were scored 
per experimental condition in each of three experiments. Note from panels A) and B) that TSA 
inhibited WT MEFs to an extent similar to HDAC6 KO, and TSA produced no discernible 
further inhibition of KO MEFs, compared to DMSO treatment of HDAC6 KO MEFs.  Asterisks 















Supplementary Figure 2.  Tubacin treatment of WT MEFs results in loss of polarization of 
the Ac MT array and cellular organelles. 
Quantification of polarized A) Ac MT arrays and B) cellular organelles in wound-edge, 
tubacin-treated WT MEFs.  Cells were wounded, treated as indicated and allowed to polarize for 
5 hours before they were fixed and immunolabeled with antibodies against Ac and total tubulin 
in A), and Glu tubulin antibody (to detect stable, Glu MTs and MTOCs), and Golgi and 
vimentin antibodies in B). In A) and B) at least 200 cells were scored per experimental condition 
in each of three experiments. Asterisks indicate significance (p<0.05) as compared to DMSO-
treated WT MEFs. C) Western blots were performed on WT and HDAC6 KO MEFs in order to 
compare the effects of TSA and HDAC6 KO versus tubacin on the level of hyper-Ac tubulin. 
Cells were treated as indicated for 4 hours before harvesting. Blots were labeled with antibodies 















































































































Supplementary Figure 3. Loss of HDAC6 inhibits polarization of mitochondria towards the 
leading edge.  
A) Micrographs and B) quantification of mitochondrial polarization in wound-edge WT 
and HDAC6 KO MEFs. A) MEF monolayers were wounded and allowed to polarize for 5 hours 
and treated with a mitochondrial fluorescent dye before fixation. Bar, 10 µm. B) At least 200 
cells were scored per experimental condition in each of three experiments. Asterisks indicate 























Supplementary Figure 4.  Loss of HDAC6 increases cell spreading.  
Quantification of spreading in WT and HDAC6 KO MEFs. Total cell area at different 
times after cell plating on glass coverslips was measured and plotted. At least 25 cells per time 























Our results provide strong support for our original hypothesis, that HDAC6 activity is 
required for MT-dependent cellular polarization and polarized intracellular transport in 
directional migration of fibroblasts. Below we discuss how our data, taken together with other 
findings, also contribute to answering three questions that extend from our hypothesis: First, in 
the absence of HDAC6 activity, what proteins become hyperacetylated, and thus potentially 
reduce motility? Second, what is/are the mechanism(s) by which HDAC6 activity impinges upon 
MT-dependent fibroblast polarization and directed motility? Third, are TSA’s anti-motility 
effects on wound-healing likely to be replicated in clinical regimens using TSA or other 
hydroxamic acid HDAC inhibitors (Drummond et al., 2005; Minucci and Pelicci, 2006)?  
Addressing the first question, of all the known in vivo HDAC6 substrates only three, i.e., 
tubulin (e.g., Hubbert et al., 2002); Hsp90 (Bali et al., 2005; Kovacs et al., 2005); and cortactin 
(Zhang et al., 2007) are known to be directly involved in cell motility. Using our KLAC antibody 
(Tran et al., 2007)  that was designed to react with all Ac-lysines irrespective of the surrounding 
sequence, we show here that tubulin was the only one whose acetylation level detectably 
increased in HDAC6 KO and HDAC6-inhibited WT fibroblasts; an important result as no other 
study has simultaneously investigated the acetylation states of all three of the HDAC6 motility-
related substrates to our knowledge. Presumably, like cortactin (Zhang et al., 2007), but unlike 
tubulin, Hsp90 is not deacetylated exclusively by HDAC6 in motile fibroblasts and may be 
deacetylated by SIRT2. Pharmacological experiments first suggested that more than one HDAC 
class deacetylates Hsp90 (Blagosklonny, 2002), which possesses multiple acetylation sites 
(Scroggins et al., 2007). Our observation that Hsp90 acetylation level was unchanged by HDAC6 





to others (Bali et al., 2005; Gao et al., 2007; Zhang et al., 2007). Plausible explanations for these 
discrepant results are that the levels of several HDACs vary with cell type or growth conditions 
(Dangond et al., 2001; Dryden et al., 2003), or that detection of Hsp90 acetylation varies with 
different antibodies or methods of assay. Thus, although cortactin and Hsp90 affect cell motility 
(Gao et al., 2007; Zhang et al., 2007), the HDAC6 substrate and interacting protein, tubulin and 
its polymer, are the most likely contributors to the motility inhibition we measured here. 
However, the overexpression of both WT and a non acetylatable tubulin mutant 
sufficiently and equivalently rescued the Golgi vesicle motility defect in HDAC6 KO MEFs. 
While this result unequivocally shows a MT-dependent effect for HDAC6 activity and points to 
the relevance of the acetylated MT subset to the effects we have reported here, we cannot as of 
yet conclusively conclude that hyperacetylated MTs are the sole cause underlying these effects 
as the effects could be mediated by some other property of MTs, by an overall increase in total 
MT polymer level, or a failure to sufficiently acetylate tubulin residues overexpressed by the WT 
mutant. It is thus possible that one or more of the other identified substrates of HDAC6 (see non-
motility related substrates in Table 1, Chapter 1) also modulate their effects on MT-based 
transport and polarization in migrating cells. Of these, β-catenin seems the most likely candidate 
to influence directional migration due to its functions in the classical Wnt signaling pathway and 
in cell-cell adherens junctions which are deregulated in many cancers (Li et al., 2008). However, 
none of these other substrates are known to be direct cell motility modifiers and whether altering 
the acetylation state of β-catenin or any of the other substrates contributes to altering directional 
migration indirectly or by as yet undiscovered function(s) remains to be determined.  
It is also likely that HDAC6 has substrates involved in the regulation of cell motility that 





the formin, mDia (Destaing et al., 2005), GSK3β (Chen et al., 2010), PP1 (Brush et al., 2004), or 
SIRT2 (North et al., 2003), suggests that HDAC6 may deacetylate these or other substituents of 
these protein complexes, many of which are known to interact with and impact the function of 
MTs. Any putative HDAC6 substrate dependent exclusively upon HDAC6 or other NAD-
independent HDACs for its deacetylation would become hyper-Ac in HDAC6 KO or TSA-
treated fibroblasts, respectively, thus possibly contributing to decreased cell polarization and/or 
motility. To have escaped detection thus far, such a hyper-Ac protein would likely be present in 
small amount; nevertheless, it could contribute an important signaling function in motile 
fibroblasts. In addition, we predict that motility defects would be markedly enhanced in 
fibroblasts lacking both HDAC6 and SIRT2, i.e., cells with hyper-Ac tubulin, cortactin, and 
possibly Hsp90 or other HDAC6 substrates. This prediction is amenable to test, using mice null 
for HDAC6 (Gao et al., 2007; Zhang et al., 2008) and SIRT2 (Vaquero et al., 2006).  
Turning to our second question, there are several possible mechanisms of action of 
HDAC6 activity that might explain the MT-based defect in cellular polarization and intracellular 
transport. Migrating cells polarize stable MTs and other organelles (Bulinski and Gundersen, 
1991), and Golgi-derived vesicle trafficking towards the leading edge, possibly to optimize the 
directional membrane turnover required for persistent direction of migration (Bergmann et al., 
1983; Prigozhina and Waterman-Storer, 2004; Schmoranzer et al., 2003). Loss of HDAC6 
activity abrogated polarization of organelles, i.e. the stable MT subset, the MTOC, the Golgi 
complex, the vimentin intermediate filament array and mitochondria, towards the leading edge. 
Testing components of the MTOC reorientation pathway revealed that loss of HDAC6 activity 
inhibited localizations of the MT plus-end binding protein p150glued and cortical dynein which 





bidirectional transport of Golgi vesicles was also decreased suggesting an inhibition in the 
binding and/or activities of these motors on MTs. 
 Loss of HDAC6 activity results in a global acetylation of tubulin such that virtually 
every MT appears completely modified. One possible ramification of hyperacetylation of almost 
all tubulin subunits is that it could likely alter polymerization or surface structure of MTs; either 
would be expected to decrease the binding of MTs to +TIPs and motors thereby decreasing local 
MT capture and stabilization, and motor transport. Our data showing the decreased localization 
of the +TIP p150glued and decreased bidirectional motor-based transport are consistent with this 
premise. p150glued is proposed to mediate docking of dynein to both MTs and cargoes via a 
search-capture mechanism (Vaughan, 2005), and to enhance dynein processivity (Culver-Hanlon 
et al., 2006). Moreover, p150glued has been shown to activate kinesin-based transport as well as 
dynein (Berezuk and Schroer, 2004; Haghnia et al., 2007). Thus, loss of its localization on 
hyperacetylated MT plus-ends would attenuate the activities of both dynein and kinesin on MTs 
leading to decreased bidirectional transport. Our results are consistent with both dynein and 
kinesin loading and processivity defects in HDAC6-inhibited fibroblasts, since many vesicles did 
not move at all and those that did showed decreased run time of retrograde and anterograde 
motility. Alternatively, decreased motor binding to hyperacetylated MTs, independent of any 
role of p150glued, would also decrease bidirectional transport of vesicles thereby contributing to 
decreased directional migration. The decreased Golgi vesicle motility in HDAC6-inhibited cells 
could in turn impact migration through the failure of polarization of the Golgi from which stable 
MTs often emanate (Efimov et al., 2007).  
Hyperacetylation of virtually all cellular MTs could also delocalize signaling pathways 





of a stable, posttranslationally modified array is thought to be important for directional migration 
perhaps because stable MT arrays serve as long-lived tracks for reiterative intracellular transport 
events. Additionally, temporal and spatial regulation of MT stabilization and modification early 
in the polarization process in directionally migrating fibroblasts (Bulinski and Gundersen, 1991) 
is thought to be important for signaling downstream pathways that trigger global organelle 
polarization towards the leading edge. The loss of spatial information by hyperacetylation of all 
cytoplasmic MTs could hamper the localized recruitment of proteins at the leading edge 
preventing polarization of organelles and transport along oriented MT tracks marked specifically 
by acetylation. This premise is supported by our findings that HDAC6-inhibited fibroblasts did 
generate stabilized MT arrays, even though they failed to reorient these or other organelles 
towards the leading edge. In addition to the loss of HDAC6 activity substantially reducing the 
plus-end localization of p150glued, HDAC6-inhibited fibroblasts also failed to localize cortical 
dynein involved in MTOC reorientation. Naturally, mislocalization of dynein at the leading edge 
would significantly lower the likelihood of leading edge MT capture and MTOC reorientation.  
Mechanisms for localizing dynein at the leading edge have not been described; thus, we 
can only speculate on the impact of HDAC6 activity and hyperacetylated MTs on this process. 
Lipid raft redistribution to the leading edge of migrating cells, activating PI3K signaling 
pathways, and recruiting proteins with plekstrin homology (PH) domains to the cortex (reviewed 
in Manes et al., 2003), may be involved in leading edge localization of dynein. While no dynein-
interacting PH domain protein has been described in higher eukaryotes, at least in yeast, a PH-
domain containing protein, Num1p, has been proposed as the cortical anchor for dynein 
(Yamashita and Yamamoto, 2006). Moreover, evidence of crosstalk among lipid rafts, Rho 





al., 2003). Although these processes occur downstream of actin reorganization (Manes et al., 
2003), feedback loops between MTs and small GTPases have been reported in which MTs also 
interact with regulatory subunits of PI3K (reviewed in Wittmann and Waterman-Storer, 2001).  
Thus, it is possible that a feedback loop exists in which MTs or Ac MTs regulate upstream 
signaling pathways that then activate MT capture. Another possibility is that accumulation of 
dynein at the cortex may also require its loading onto MTs (Sheeman et al., 2003; Xiang, 2003) 
via the MT-loading factor, p150glued (Vaughan, 2005). Alternatively, dynein may undergo 
kinesin-based transport to the leading edge, as this occurs in Aspergillus (Zhang et al., 2003a). 
Thus, defects in bi-directional MT-based transport in HDAC6-inhibited cells may abrogate 
redistribution of dynein to the leading-edge cortex. 
Altered MT dynamics of hyperacetylated MTs in HDAC6-inhibited fibroblasts (Tran et 
al., 2007) may provide yet another mechanism for the defect in MTOC reorientation which 
involves interaction of p150glued on dynamic MTs with cortical dynein (reviewed in Gundersen 
et al., 2004). Dampening of MT dynamics by a low dose of Taxol has been shown to inhibit the 
binding of a p150glued-related +TIP, CLIP170, to MT plus ends (Perez et al., 1999) The reduced 
dynamics of MTs in HDAC6-drug inhibited (Tran et al., 2007) fibroblasts may suffice to reduce 
the MT-binding affinity of p150glued which would inhibit cortical docking. The result that both 
MT dynamics and p150glued binding to MT ends are reduced in HDAC6 KO fibroblasts 
corroborates the findings that MTOC reorientation requires both dynein function and dynamic 
MTs (Yvon et al., 2002; Gomes et al., 2005). Reduced dynamics of MTs would also decrease the 
probability of MT targeting to leading edge docking sites thereby impacting cell motility directly 





Finally, decreased or disrupted binding of inhibited HDAC6 with its interacting partners, 
p150glued and dynein, can also contribute to the decreased bidirectional motor-based transport 
we observe. Dynein directly binds HDAC6 (Kawaguchi et al., 2003), and tubacin has been 
shown to disrupt this binding (Hideshima et al., 2005). Thus, the loss of HDAC6 or its activity 
could either directly decrease dynein loading onto MTs, or indirectly by inhibiting p150glued 
plus-end binding, causing the decreased dynein-based motility. This can also explain the 
inhibition in dynein’s cortical leading edge localization as HDAC6 itself is specifically localized 
to the leading edge cortex (Gao et al., 2007; Hubbert et al., 2002). While it is not known whether 
HDAC6 directly interacts with  kinesin, kinesin-based transport of parkin was inhibited in 
tubacin and TSA treated cells (Jiang et al., 2008). Moreover, HDAC1 has recently been 
discovered to be present in the cytoplasm in neurodegenerative disease, where it has been shown 
to bind kinesin-1 thereby decreasing kinesin-cargo interactions and detrimentally inhibiting 
axonal transport (Kim et al., 2010). These results suggest that HDAC6 also regulates kinesin-1 
activity. Interestingly, the MT motor kinesin-1 has been shown to regulate focal adhesion 
turnover (Krylyshkina et al., 2002), which we have previously shown is inhibited in HDAC6 KO 
MEFs by dampened MT dynamics (Tran et al., 2007). The inhibition of kinesin loading onto 
MTs by loss of HDAC6 or its activity may thus alternatively explain the decreased kinesin-based 
motility.  
However, the decrease in MT-based dynein and kinesin vesicle transport we observed in 
HDAC6 null and inhibited fibroblasts appears inconsistent with the increased bidirectional 
dynein and kinesin-based MT transport observed in neuronal cells (Dompierre et al., 2007; Reed 
et al., 2006). However, those data are hard to interpret as they could be due to the effects of 





conflicting data showing that MT acetylation is not sufficient for preferential transport in 
neurons and requires a combination of MT modifications including acetylation, detyrosination 
and polyglutamylation (Hammond et al., 2010). Our data on the other hand are consistent with a 
role reported for HDAC6 deacetylase activity being required for the anterograde and retrograde 
transport of parkin by kinesin and dynein, respectively (Jiang et al., 2008).  Thus, deacetylation 
of acetylated residues along the MT track in normal cells could be important for the regulation of 
transport of organelles and vesicles required for steady-state homeostasis or other cellular 
activities; increased MT hyperacetylation could inhibit bidirectional motor-based transport as an 
effect of inhibition or loss of HDAC6 activity. Alternatively, it is possible that transport of 
different cargoes or by different kinesin family members are selectively regulated by MT 
acetylation (Carta et al., 2006; e.g., Hirokawa and Takemura, 2005; Ikegami et al., 2007; 
Naranatt et al., 2005).   
At first glance, one would expect inhibition of bidirectional trafficking to be compounded 
in axonal transport, in which cells use numerous reiterative transport events to generate 
movement over long distances. However, HDAC6 KO mice are viable (Gao et al., 2007; Zhang 
et al., 2008), without gross brain defects (Zhang et al., 2008).  Perhaps, the fact that HDAC6 
expression is low and the tubulin is heavily Ac in brains of WT mice (Zhang et al., 2008) 
predicts that a small further increase in tubulin acetylation in HDAC6 KO mice would have no 
effect, or would yield only subtle behavioral effects (as reported by Fukada et al., 2012). In other 
tissues, hyper-acetylation of MTs could compromise wound healing or alter tumorigenicity or 
metastatic potential. The immune system defects of HDAC6 KO mice (Zhang et al., 2008) are 
consistent with the previous demonstration that MTOC reorientation in immune cell function 





Concerning the last question, the extraordinary promise of HDAC inhibitors as anti-
tumor agents, (Drummond et al., 2005; Minucci and Pelicci, 2006) makes it useful to assess the 
potential relevance of our results to the action of these drugs in people. Most current studies of 
the anti-oncogenic potential of HDAC inhibitors addresses their effects on gene expression 
pathways involved in cell proliferation, differentiation, apoptosis, and angiogenesis (reviewed in 
Drummond et al., 2005).  It is difficult to extrapolate from in vitro assays of mouse fibroblast 
motility in culture to motility effects of tumor cells in vivo in humans. We do note, however, that 
we measured motility deficits in HDAC-inhibited fibroblasts both in 3D (Tran et al., 2007), and 
2D-motility, which we explored in depth here. Similar motility defects are likely to be replicated 
in vivo, especially when hydroxamic acid-type HDAC inhibitors are used to treat mouse models 
of sarcomas, which maintain numerous motility and morphology characteristics of the fibroblasts 
from which they arise (Johnson et al., 1971; Paku et al., 2003; Sroka et al., 2002). The HDAC6-
selective drug, tubacin, inhibits 3D invasion motility (Haggarty et al., 2003), and its inhibition is 
as potent as that of TSA (Tran et al., 2007). However, tubacin also greatly enhances cytotoxicity 
in multiple myeloma cells, when used in conjunction with a known anti-tumor drug (Hideshima 
et al., 2005). Thus, the degree to which HDAC inhibitor effects on cell motility prove to be 
beneficial contributors to the overall anti-tumor effects of these drugs remains to be seen.   
In summary, our study provides plausible mechanisms for the roles of HDAC6 and MTs 
in directionally migrating fibroblasts. These results may have long term implications in the drug-
targeting of diseases that involve aberrant cell migration, and/or in understanding of off-target 







MATERIALS AND METHODS 
Cell culture and treatments 
Experiments were performed in wild type (WT) and HDAC6 knockout (KO) MEFs 
(Boyault et al., 2008) and corroborated in A549 and HDAC6 knockdown (KD) A549 cells 
(Kawaguchi et al., 2003). All cells were cultured in DMEM supplemented with 10% fetal bovine 
serum, while all drugs except water-soluble sodium butyrate (NaB) were dissolved in DMSO, 
whose final concentration in media of treated cells was < 0.1%. Rescue experiments were 
performed in HDAC6 KO MEFs by transient transfections of HDAC6 WT, WT-FLAG--
tubulin, and K40R-FLAG-α-tubulin constructs co-transfected with GFP for visualization. GFP 
constructs alone were expressed as controls. Low to moderate expressors were chosen for data 
analysis. 
 
Antibodies and reagents 
All antibodies and chemicals were purchased from Sigma-Aldrich unless indicated. 
Antibodies specific to detyrosinated (Glu) and tyrosinated tubulin were described in Gundersen 
at al. (1984). Antibodies to β-tubulin (3F3); p150glued; and dynein intermediate chain (DIC) 
were generous gifts from Drs. J. Lessard (University of Cincinnati), K. Vaughan (University of 
Notre Dame) and Vallee (Columbia University), respectively. Anti-Golgi (GM130), and anti-
EB1 antibodies were from BD Transduction Laboratories (Lexington, KY). Monoclonal 
cortactin antibody (clone 4F11) was purchased from Upstate (Millipore) (see Zhang et al., 2007). 
Anti-acetylated lysine antibody (Keyhole Limpet Ac antibody, or KLAC) (Tran et al., 2007) was 
raised against Keyhole Limpet Hemocyanin that was chemically acetylated by reaction with 





binding to and low pH elution from chemically acetylated Keyhole Limpet Hemocyanin-Agarose 
beads. Specificity of KLAC antibody for the -amino acetylation of lysines was determined by 
preabsorption of the antibody with 1mM N-epsilon-acetyl-L-lysine (N-e-Ac-L-K) for 1 hour at 
room temperature. Sirtinol was purchased from Calbiochem. Mitotracker Red CMXRos was 
purchased from Invitrogen. 
 
Immunoprecipitations, immunoblotting and immunofluorescence 
Cortactin immunoprecipitates (IPs) were prepared from MEF lysates under identical high 
stringency conditions and using the same source of cortactin antibody as described in Zhang et 
al. (2007).  All western blots of whole cell extracts and immunofluorescence of fixed cells were 
performed as described in Chang et al. (2002). 
 
Wound healing migration assays 
Cells were seeded overnight at a density of 1 x 10
6
 per acid-washed glass coverslips to 
form confluent monolayers; after 16 hours they were wounded as described (Gundersen and 
Bulinski, 1988).  For velocity measurements, coverslips were fixed at 0-10 hour time intervals in 
3.7% formaldehyde. Phase micrographs (> 15) of wound margins were obtained for each time 
point with a CoolSNAP-fx cooled-CCD camera (Photometrix, Roper, NJ) and wound-closure 
rate was measured as described by Yvon et al. (2002).  Average velocities (reported in µm/hour) 
were divided by two to obtain rates of movement in a single direction.   
 





Polarization of cellular organelles and cortical leading edge markers was quantified in 
fixed and immunolabeled wound-edge cells as described (Finkelstein et al., 2004). The 
localization of cortical dynein at the leading edge was analyzed in parallel with analysis of MT 
ends that converged at these lamellipodial regions (Dujardin et al., 2003). MT plus end 
localization of +TIP p150glued was quantified in sparse cells from immunofluorescence images 
double-labeled for p150Glued and β tubulin; pixel intensities, for a total of > 1000 MTs were 
quantified from 15 cells per cell type with MetaMorph software (Molecular Devices, 
Downingtown, Pennsylvania). 
 
Time-lapse Imaging of Golgi vesicles and cell migration 
Imaging of both live and fixed cells was performed as described by Tran et al. (2007), 
unless indicated. Golgi vesicle motility in sparse or wound-edge cells was visualized using 
BODIPY TR ceramide [N-((4-(4,4-difluoro-5-(2-thienyl)-4-bora-3a,4a-diaza-s-indacene-3-
yl)phenoxy)acetyl] sphingosine (Invitrogen, Carlsbad, CA).  Vesicles were analyzed in areas of 
whole cells according to the criteria specified by Hamm-Alvarez et al. (1993). The following 
vesicle motility parameters were quantified using the ‘Track Points’ function in MetaMorph: 
average velocity, maximum velocity, run length, run time, and percentage of motile vesicles;  
1000 vesicles total in 15 cells per cell type were analyzed. 
 
Brefeldin recovery assay 
WT and HDAC6 KO MEFs were sparsely seeded on coverslips and allowed to grow overnight. 
Cells were treated with 1 µg/ml Brefeldin A (BFA) for 45 minutes and allowed to recover in 





intervals of 0, 5, 15 and 45 minutes and at 1, 1.5 3, and 5 hours during 0 to 5 hours by methanol 
fixation and immunofluorescence with Golgi GM130 antibody. Golgi clustering was scored as 
described in Bulinski et al. (1997) and data plotted to quantify rates of Golgi recovery from BFA 
treatment. 
 
Assay of mitochondrial area in spreading cells 
WT and HDAC6 KO cells pretreated with 100nM MitoTracker Red CMXRos for 15 minutes 
were rinsed, trypsinized and re-plated on coverslips to analyze and quantify mitochondrial area 
in spreading cells. Cells were fixed in 3.7% formaldehyde at regular intervals during 0 to 6 hours 
of plating, and then permeabilized in 0.1% Triton X-100. Images were taken and processed with 
the threshold function in Image J software to calculate mitochondrial area. Data were plotted as a 
percentage of total cell area to compensate for inherent cell spreading differences in WT and 
HDAC6 KO MEFs. At least 20 cells per time point and condition were used for analysis. 
 
Data Analysis  
Data from all cellular motility, immunofluorescence, western blot, and IP experiments 
were quantified from at least three independent experiments. For microscopic scoring, at least 
200 cells or fields of view were scored for each experimental condition. Statistical significance 















HDAC6 regulates cellular polarization by mediating cortical-microtubule 
















 HDAC6 activity regulates directional migration of fibroblasts through MT-dependent 
effects on polarization of cellular organelles and directed organelle and vesicular intracellular 
transport (Salam et al., manuscript in preparation, see Chapter 2). Loss or inhibition of HDAC6 
activity resulted in a global defect in polarization of organelles including inability of HDAC6 
null fibroblasts to reorient their MTOCs. Experiments to elucidate a mechanism for defects in 
MTOC reorientation in HDAC6 null fibroblasts revealed decreased localizations of two factors 
involved in the MTOC reorientation pathway: p150glued, a MT +TIP protein that binds to 
growing or dynamic MT ends was inhibited in its localization to MT plus tips, while its receptor, 
cortical dynein, was inhibited in its leading edge localization in migrating cells (Dujardin et al., 
2003; Gomes et al., 2005). Furthermore, both dynein-mediated and kinesin-mediated MT 
organelle and vesicle transport was inhibited in motile cells. We also observed defects in the 
elaboration of a stable, modified MT array oriented towards the leading edge (Chapter 2) 
suggesting that loss of HDAC6 activity may impact MT stabilization pathways in migrating 
cells.  
 MTs play essential roles in polarizing cellular organelles in persistent directional 
migration (Glasgow and Daniele, 1994; Wittmann and Waterman-Storer, 2001). One of the 
earliest detectable steps in the polarization of fibroblasts towards an experimental wound is the 
selective stabilization of a subset of MTs whose distal (i.e., plus) ends are situated in the cortical 
region of the cell, closest to the wound edge (Gundersen and Bulinski, 1988). While most MTs 
in fibroblasts are highly dynamic, exhibiting a turnover half-time of 6-10 min (Schulze et al., 
1987), the plus ends of MTs that face the wound edge appear to be capped (Infante et al., 2000), 





Two distinct molecular mechanisms have been elucidated by which wound-edge MTs 
become selectively stabilized: Akhmanova et al. (2001) found that CLIP-170, called a +TIP 
because it is normally bound to the plus ends of dynamic MTs, recruits CLIP-170-associated 
proteins (CLASPs) to MT tips; this complex then stabilizes MTs by attaching their plus ends to 
the cell cortex through association of CLASPs with the cell cortex components, LL5 and ELKS 
(Lansbergen et al., 2006). Concurrently, Palazzo et al. (2001a) found that RhoA stabilizes MTs 
through its downstream mediator, mDia; mDia binds additional proteins, APC and EB1, and 
these then bind to and stabilize MT plus ends (Wen et al., 2004).  
Interestingly, GSK3β is involved in the regulation of both MT stabilization pathways. 
GSK3β is negatively regulated by mDia1 in the MT stabilization pathway involving EB1 and 
APC (Eng et al., 2006; Wen et al., 2004). The inhibition of GSK3β, which inhibits HDAC6 
(Chen et al., 2010) is also involved in the regulation of CLASP2 (Akhmanova et al., 2001; 
Kumar et al., 2009; Lansbergen et al., 2006; Watanabe et al., 2009; Wittmann and Waterman-
Storer, 2005). Phosphorylation of CLASP2 by active GSK3β disrupts the localization of 
CLASP2 and EB1 from MT plus ends (Watanabe et al., 2009). Furthermore, GSK3β may 
coordinate the actin and the MT networks required for efficient cell migration via regulating the 
interaction between CLASP2 and IQGAP1 which can bind both actin and MTs. Although the 
interface between the two MT stabilization mechanisms is not understood, a link between mDia 
and HDAC6 (Bershadsky et al., 2006) and GSK3β and HDAC6 (Chen et al., 2010) may 
implicate HDAC6 in wound-edge MT stabilization.  
Based on that MT +TIPs are involved in conserved MT capture mechanisms involved in 
cellular polarization (Gundersen et al., 2004), that p150glued and dynein localizations were 





modified MT arrays were not oriented towards the leading edge, we hypothesized that loss of 
HDAC6 activity in HDAC6 null fibroblasts regulates MT stabilization pathways. Here we report 
our data on MT +TIP localization involved in the two other, independent MT stabilization 
pathways showing that only the pathway involving CLASP2 and its cortical receptor LL5β is 
























Loss of HDAC6 inhibits localization of CLASP2, and its cortical receptor LL5β 
Accumulation of cortical proteins at the leading edge is an early step in the polarization 
response to monolayer wounding (Dujardin et al., 2003; Lansbergen et al., 2006). The plus ends 
of MTs that approach the wound edge of cells have been shown to be stabilized through the 
binding of +TIP family proteins (Carvalho et al., 2003). Previously, we showed that a +TIP-
cortex interaction mediated by p150glued, a +TIP and dynein adaptor, by docking with dynein 
anchored in the leading-edge cortex of motile cells (Etienne-Manneville and Hall, 2001; Gomes 
et al., 2005; Palazzo et al., 2001b) was altered by loss of HDAC6 in HDAC6 KO MEFs leading 
to MTOC reorientation defects. We investigated a parallel pathway in cells which is involved in 
MT stabilization (Lansbergen et al., 2006), involving the MT + TIP CLASPs (Akhmanova et al., 
2001) which dock MT plus ends to leading edge plasma membrane receptors such as LL5 
(Lansbergen et al., 2006).  
CLASPs and LL5β specifically redistribute to the leading edge lamellipodia at the onset 
of cellular migration (Akhmanova et al., 2001; Lansbergen et al., 2006). To address the 
mechanism(s) underlying defects in the formation of properly oriented stable MTs we localized 
CLASP2 (Figs. 1A and 1B) and its docking receptor, LL5 at the leading-edge cortex in wound-
edge cells (Figs. 1C and 1D) in WT and HDAC6 KO MEFs. Analogous to the factors involved 
in the MTOC reorientation pathway (Chapter 2), both markers were markedly reduced in their 
localization at the cell cortex in HDAC6 KO MEFs and few MT ends converged at the cell 
cortex facing the wound edge were CLASP2 or LL5β positive (Fig 1 A-D). Like dynein, while 
the noticeably fewer cortical CLASP2 and LL5β patches in HDAC6 KO cells almost entirely 





enriched in converged MT distal end networks were markedly reduced for cortical CLASP2 and 
LL5β localization (Fig. 1 A-D) in HDAC6 KO MEFs as compared to their WT counterparts. 
These data indicate that like factors involved in MTOC reorientation, CLASP2 and LL5β are 
inhibited in their localizations to the cortex providing a mechanism for the defect in polarization 
of a stable, modified MT array oriented towards the leading edge in directionally migrating cells 
(Chapter 2). 
 
Loss of HDAC6 inhibits localization of CLASP2 at MT plus ends but not of EB1 or 
CLIP170 
Since CLASP2 cortical localization was inhibited we wanted to test whether CLASP2 
MT plus tip localization is also altered by loss of HDAC6 in HDAC6 KO MEFs. To assay this 
we immunolabeled and quantified the number of MT plus ends positive for CLASP2 
localization, as described for p150glued (see Materials and Methods). HDAC6 KO MEFs 
showed greatly reduced CLASP2 localization on MT plus ends (~ 60%, Figs. 2A and 2B), 
reminiscent of our previous results with p150glued. Thus, CLASP2 localization is inhibited both 
at the leading edge cortex and on MT plus ends by loss of HDAC6 and provides a mechanism for 
the defect in orientation of a stabilized, oriented MT array at the leading edge in migrating cells. 
Since CLASPs are thought to be recruited by CLIP170 onto MT plus ends (Akhmanova 
et al., 2001), we assayed whether CLIP170 localization is affected in HDAC6 KO MEFs to begin 
to elucidate mechanisms affecting CLASP2-MT plus end localization. Moreover since CLIP170 
is known to provide the link between dynein and its cargo, and dynein-mediated MT based 
transport and dynein’s cortical localization was affected by loss of activity of HDAC6, we 





addition, we also determined whether EB1, which is a downstream factor for mDia in the 
alternate MT stabilization pathway (Eng et al., 2006; Palazzo et al., 2001a; Wen et al., 2004), 
and is thought to stabilize MTs by specifically binding to the MT GTP cap, is inhibited in its 
ability to interact with MT plus ends in HDAC6 KO MEFs.  
To test these possibilities, we quantified the localizations of CLIP170/CLIP115 and EB1, 
which are implicated in dynein function (Pierre et al., 1992) and MT stabilization (Akhmanova et 
al., 2001; Wen et al., 2004), respectively.  However, no reduction in the distributions of CLIP170 
(data not shown) or EB1 (Fig. 2C and D) on MT distal ends was observed in the absence of 
HDAC6 protein. These data suggest that CLIP170 is not involved in the CLASP2 MT 
stabilization or the dynein MTOC reorientation pathways. Although, we did not assay APC, the 
other +TIP involved in the EB1 MT stabilization pathway, the localization with EB1 suggests 
that perhaps this MT stabilization pathway is not regulated by HDAC6 activity. These data, 
together with our data on p150glued and dynein, suggest that loss of HDAC6 activity decreases 
MT-cortex interactions by inhibiting localizations of cortical membrane proteins and their +TIP 
MT-linking partners in both MTOC reorientation and MT stabilization pathways, thus providing 































































Figure 1. Loss of HDAC6 inhibits localization of CLASPs and their cortical docking 
protein, LL5β, to MT plus-ends and the leading edge.   
A) Micrographs and B) quantification (see Materials and Methods) of leading edge 
localization of CLASP2.  C) Micrographs and D) quantification of leading edge localization of 
LL5β, as in B). A) and C) WT and HDAC6 KO MEF monolayers were wounded and allowed to 
polarize for 5 hours before they were fixed and immunolabeled with antibodies against 
CLASP2, LL5β and total (β) tubulin. White arrows indicate CLASP2- or LL5β-positive 
leading edge regions in WT MEFs where MTs were observed to converge. Wound edges are 
indicated by black arrows. Bar, 10 µm. B) and D) Asterisks indicate significant differences, 






















































































Figure 2. Loss of HDAC6 inhibits localization of CLASP2, but not EB1, to MT plus-ends.  
A, and C) Micrographs and B, and D) quantification (see Materials and Methods) of 
CLASP2, and EB1 localization on MT plus ends in sparse WT and HDAC6 KO MEFs, labeled 
with CLASP2 and total (β) tubulin antibodies in A), and EB1 and total  tubulin antibodies in 









Taken with our previous results, our data demonstrate HDAC6 enzymatic function in two 
non-overlapping pathways, polarization of the stable MT array, and reorientation of the MTOC 
(e.g., Drabek et al., 2006; Dujardin et al., 2003; Palazzo et al., 2001a; Palazzo et al., 2001b). The 
MT stabilization and MTOC reorientation pathways are independent, but nonetheless parallel, 
involving interaction of a +TIP on a dynamic MT, (CLASP or p150glued, respectively) with a 
cortical receptor concentrated at the leading edge (LL5 or dynein) (reviewed in Gundersen et 
al., 2004). The fact that loss of HDAC6 yields a more pronounced reduction in fibroblast 
migration than either CLASP2-depletion (Drabek et al., 2006) or dynein-inhibition (Dujardin et 
al., 2003) corroborates the notion that HDAC6-inhibition impacts on both stable MTs and 
MTOC polarization pathways.  
Loss of HDAC6 substantially reduced the localizations of the +TIP CLASP2 on MT ends 
and in the cortex, as well as its cortical receptor, LL5, thereby inhibiting the formation of a 
stable MT array oriented towards the direction of migration in motile fibroblasts. Conversely, 
EB1 localization was not altered in HDAC6 null fibroblasts suggesting that the EB1 MT 
stabilization pathway is active and functional in these cells. In support of this, MT stabilization 
of a select subset of MTs was not found to be inhibited in wound-edge cells, its orientation was. 
Also unlike CLASPs, which are selectively localized to the leading edge, EB1 does not 
redistribute to the leading edge upon the onset of directional migration (Lansbergen et al., 2006). 
This implies that while both the CLASP2 and the EB1 pathways can stabilize MTs, the 
regulation of the LL5β-CLASP2 pathway by HDAC6 is critical for the formation of oriented 





On analysis, the MT +TIP binding profile in HDAC6 null fibroblasts is perplexing, 
making it hard to pinpoint a common mechanism of altered localization of these proteins. 
HDAC6 has been reported to interact with several MT + TIPs including p150glued (Hubbert et 
al., 2002; Kawaguchi et al., 2003), Arp1 and EB1 (Zilberman et al., 2009). While some of these 
are CAP-GLY domain containing proteins like p150glued, Arp1, and CYLD (Kawaguchi et al., 
2003; Wickstrom et al., 2010; Zilberman et al., 2009), others like EB1 (Zilberman et al., 2009) 
and CLASP2 are not. Thus, while it is not surprising that loss of HDAC6 inhibited the MT plus 
end localization of p150glued, it is surprising that the localization of CLIP170 was not inhibited, 
as both are CAP-GLY +TIPs. Paradoxically, the MT plus end localization of EB1, which also 
binds HDAC6 (Zilberman et al., 2009), was not affected in HDAC6 null fibroblasts, consistent 
with the observation that in experiments with HDAC6 KD cells only Arp1, a CAP-GLY protein, 
but not EB1, was affected in its pattern of localization on MT plus ends (Zilberman et al., 2009). 
It is equally intriguing that CLASP2 localization was inhibited by loss of HDAC6, while the 
localization of the CAP-GLY containing, p150glued-related CLIP170 which helps to recruit 
CLASPs on MT plus ends (Akhmanova et al., 2001) was not. It remains to be shown whether 
CLASPs and CLIP170 bind HDAC6. 
EB1 is an interesting and unique MT +TIP protein as it can bind MTs independently of 
other MT +TIP and binding partners (Dixit et al., 2009). EB1 is postulated to be the key 
recruiting factor that establishes a hierarchy of different complements of +TIPs at the MT plus 
ends, as it can bind almost all other MT +TIPs (Akhmanova and Steinmetz, 2010). EB1’s well-
studied C-terminal EEY/F motif, which is also present in tubulin, mediates binding to CAP-GLY 
domain containing proteins like p150glued and CLIP170 recruiting them to MT plus ends. EB1 





but instead mediate binding to MTs through their TOG domains and additional SxIP motifs (Al-
Bassam and Chang, 2011; Mimori-Kiyosue et al., 2005; Slep and Vale, 2007). The N-terminal 
EB homology (EBH) domains of EB1 interact with the SxIP motifs of CLASPs thereby 
recruiting them to MT plus ends. Due to the important role of EB1 in establishing different 
networks of MT +TIPs bound to the growing, plus ends of MTs, it is not surprising that its 
localization was not altered by loss of HDAC6. Similarly, CLIP170 also plays an important role 
in hierarchical recruitment of a subset of +TIPs as it recruits CLASPs (Akhmanova et al., 2001) 
and p150glued (Lansbergen et al., 2004) to MT ends. Moreover, CLIP170 plays an essential role 
in dynein function providing a link between dynein and many of its cargoes (Pierre et al., 1992). 
The MT localization of EB1 and CLIP170 is thus probably under tight regulatory control since 
inhibition of these two +TIPs would lead to global cellular malfunction. This might explain why 
in HDAC6 null fibroblasts only the localizations of p150glued and CLASP2 are affected.  
Hyperacetylation of all MTs might affect the binding of a subset of the MT +TIPs. 
However, we cannot as yet distinguish whether it is the specific loss of HDAC6 activity or the 
physical protein that alters the +TIP protein localizations on MT plus ends as we did not 
investigate the localizations of these proteins in HDAC6 drug-inhibited cells. The moderately 
reduced dynamics of MTs in HDAC6-inhibited (Tran et al., 2007) and HDAC6-null fibroblasts 
(Tran and Bulinski, unpublished data) might not be sufficient for inhibiting MT plus end 
localization for the +TIPs we have investigated and do not provide a satisfactory explanation 
unless different MT + TIPs exhibit different sensitivities to reduction in MT dynamics. 
Dampened MT dynamics may, however, contribute indirectly to decreasing at least CLASP2-
MT binding: MT dynamics is a local regulator of Rac activity (Waterman-Storer et al., 1999), 





more detailed investigation of these possibilities will shed more light on HDAC6-mediated 
mechanisms controlling MT +TIP binding patterns in HDAC6 null fibroblasts and are the focus 
of future efforts. 
Finally, loss of HDAC6 in fibroblasts also failed to localize cortical docking proteins 
involved in leading edge orientation of the stable MT array, i.e., LL5 and CLASP2, parallel to 
cortical dynein in the MTOC reorientation pathway. Mislocalization of these cortical receptors 
further lowers the likelihood of leading edge MT capture inhibiting the formation of an oriented 
stable MT array in migrating cells. Mechanisms for localizing cortical MT receptors have not 
been well described; thus, we can only speculate on the impact of loss of HDAC6 and/or MT 
hyperacetylation. In contrast to accumulation of dynein at the cortex which may be dependent on 
its loading onto MTs (Sheeman et al., 2003; Xiang, 2003), perhaps via the MT-loading factor, 
p150glued (Vaughan, 2005) or kinesin-based MT transport (Zhang et al., 2003a), cortical 
accumulations of LL5β and CLASP2, are MT-independent (Drabek et al., 2006; Lansbergen et 
al., 2006). Interestingly, CLASP2 cortical localization, though MT-independent, appears to be 
targeted via a Golgi-based mechanism (Mimori-Kiyosue et al., 2005), thus indirectly mediated 
by MT-based transport. Thus, defects in bi-directional MT-based transport in HDAC6 null cells 
(Chapter 2) may abrogate redistribution of both dynein and CLASP2 to the leading-edge cortex. 
While it is not known whether LL5β or CLASP2 interact with HDAC6, HDAC6 itself 
could be responsible for both LL5β’s and CLASP2’s leading edge localization as it is 
specifically localized to the leading edge at the onset of fibroblast migration (Kawaguchi et al., 
2003). Lipid raft redistribution to the leading edge of migrating cells, activating PI3K signaling 
pathways, and recruiting proteins with plekstrin homology (PH) domains to the cortex (reviewed 





PI3K-regulated and has a PH domain (Paranavitane et al., 2003). Lipid rafts have been 
implicated in stabilizing MTs, by stimulating Rho GTPase signaling (Palazzo et al., 2004). 
Evidence of crosstalk among lipid rafts, Rho family members, and PI3K is proposed to establish 
and reinforce cellular polarization (Manes et al., 2003). Although these processes occur 
downstream of actin reorganization (Manes et al., 2003), feedback loops between MTs and small 
GTPases have been reported in which MTs also interact with regulatory subunits of PI3K 
(reviewed in Wittmann and Waterman-Storer, 2001).  Thus, it is possible that a feedback loop 
exists in which HDAC6, MTs or acetylated, but not hyperacetylated MTs regulate upstream 
signaling pathways that then activate MT capture. Another possibility is that HDAC6 activity, 
MTs or MT acetylation influences cellular polarization via actin regulation. Regulation of 
cortical accumulation of CLASP2, in addition to PI3K signaling (Akhmanova et al., 2001), has 
been shown to be mediated by ACF7 (Drabek et al., 2006), a MT-actin cytoskeletal linker 
protein whose loss also disrupts polarization in migrating cells (Kodama et al., 2003).  
These results, though preliminary, reveal the importance of HDAC6 in the CLASP2-
LL5β MT stabilization pathway. Elucidating the specific mechanisms that affect MT plus end 
localization of CLASP2, and not EB1 or CLIP170, and cortical accumulations of CLASP2 and 











MATERIALS AND METHODS 
Cell culture and treatments 
All cells were cultured in DMEM: Media of mouse embryonic fibroblasts (MEFs), 
generated from wild-type (WT) and HDAC6 knockout (KO, genotype, HDAC6 -/y) mice (Zhang 
et al., 2008) was supplemented with 10% fetal bovine serum.   
 
Antibodies and reagents 
All antibodies and chemicals were purchased from Sigma-Aldrich unless indicated. 
Antibodies to β-tubulin (3F3); CLASP2 and CLIP170/115; and LL5β were generous gifts from 
Drs. J. Lessard (University of Cincinnati), N. Galjart (Erasmus University), A. Akhmanova 
(Erasmus University), respectively. Anti-EB1 antibodies were from BD Transduction 
Laboratories (Lexington, KY).  
 
Quantification of cellular polarization and MT end-binding proteins 
Polarization of cellular organelles and cortical leading edge markers was quantified in 
fixed and immunolabeled wound-edge cells as described (Finkelstein et al., 2004). The 
occurrence of +TIP CLASP2 and cortical LL5β at the leading edge were analyzed in parallel 
with analysis of MT ends consolidated at these lamellipodial regions (Dujardin et al., 2003). MT 
plus end localization of +TIP CLASP2 was quantified in sparse cells from immunofluorescence 
images double-labeled for CLASP2 and β tubulin; pixel intensities, for a total of > 200 MTs 
were quantified from 15 cells per cell type, with MetaMorph software (Molecular Devices, 






Data Analysis  
Data were quantified from at least three independent experiments. For microscopic 
scoring, at least 200 cells or fields of view were scored for each experimental condition. 




































Consistent with our hypothesis that HDAC6 activity regulates important MT-dependent 
aspects of directionally migrating cells, we report here that HDAC6 enzymatic activity, and not 
level, is required for MT-dependent organelle polarization and polarized intracellular transport in 
motile fibroblasts. Of the three HDAC6 substrates directly involved in cell motility, we find that 
only tubulin’s acetylation state, and not Hsp90’s or cortactin’s, which are involved in actin-
mediated motility, was altered by abrogating or inhibiting HDAC6 activity.  
In motile cells, the early elaboration of a stable, modified MT array oriented towards the 
direction of migration is thought to template further polarization of cellular contents and 
intracellular transport (Bulinski and Gundersen, 1991; Kirschner and Mitchison, 1986). Our data 
show HDAC6 function in two independent but parallel, MT-dependent cellular polarization 
pathways: the formation of an oriented stable MT array, and reorientation of the MTOC (e.g., 
Drabek et al., 2006; Dujardin et al., 2003; Palazzo et al., 2001a; Palazzo et al., 2001b). 
Investigation into the mechanism(s) by which HDAC6 activity and its substrate tubulin or its 
acetylation/deacetylation state impacts directional migration revealed that loss of HDAC6 
activity altered localizations of particular MT plus-end binding and cortical protein partners, i.e. 
p150glued and dynein, and CLASP2 and LL5β, and/or activities of the MT motors, dynein and 
kinesin, thereby inhibiting polarization of organelles and intracellular transport towards the 
leading edge.  
By what underlying mechanism(s) does HDAC6-mediated deacetylation of tubulin 
modulate these effects in cell motility? It is possible that the binding of a subset of the MT +TIP 
or motor proteins is specifically altered by MT hyperacetylation. Chemical modification of 
tubulin subunits via acetylation could alter polymerization or surface structure of MTs. Either of 





MT targeting to leading edge docking sites. It, however, remains to be determined how MT 
acetylation may be playing a role in either signaling as the lysine 40 site of α-tubulin faces the 
MT lumen. A MT ‘breathing’ mechanism has been proposed involving the weaker heterologous 
contacts between tubulin dimers at the MT seam (Nogales, 2001); this may explain how enzymes 
and interacting proteins have quick access to this site, as the kinetics of enzymatic activity which 
are quite rapid are not consistent with slow diffusion down the inside of the bumpy MT lumen or 
through the smaller MT fenestrations inherent in the MT structure. However, as lysine 40 occurs 
on the H1-S2 loop, a region in proximity to the corresponding Taxol binding site on β-tubulin 
which stabilizes lateral protofilament contacts (Nogales, 2001), it is possible that the acetylation 
of lysine 40 in this region imparts moderate stabilization to MTs as we previously determined 
(Tran et al., 2007) and/or induces a conformational change in MT structure that alters protein-
MT interactions. Elucidating the mechanism(s) by which hyper-acetylation decreases binding of 
the +TIPs p150glued and CLASP2 and the motors dynein and kinesin to MTs will require in 
vitro binding experiments with purified Ac MTs and MAP components and is the subject of 
current efforts. 
Interestingly, only the localizations of a subset of +TIPs, namely p150glued and 
CLASP2, were inhibited in HDAC6 null fibroblasts. The reduced dynamics of hyperacetylated 
MTs in HDAC6-inhibited or knockout fibroblasts (Tran et al., 2007), may suffice to reduce the 
MT-binding affinity of these TIPs,  and not others, even though the MT binding domains of 
some of these +TIPs are similar (Carvalho et al., 2003; Perez et al., 1999; Slep and Vale, 2007). 
For example, while CLIP-170 and CLIP115 (data not shown) were not reduced on MT tips, 
p150glued was (Chapter 2). CLIP170, CLIP115 and p150glued are related MT +TIPs and 





EEE/Y motifs (Akhmanova and Steinmetz, 2010; Wickstrom et al., 2010). The localization of 
EB1, which is a different subclass of + TIPs, was also not affected. However, the localization of 
CLASP2, a distinct subclass family member that contain TOG domains (Al-Bassam and Chang, 
2011; Mimori-Kiyosue et al., 2005), which is thought to be recruited to the MT plus ends via its 
interaction with CLIP170 (Akhmanova et al., 2001), was inhibited.  
However, we previously found that the effect on MT dynamics is moderate and 
comparable to the low dose of 100nm Taxol treatment (Tran et al., 2007). Perez et al. have 
previously reported that for the related MT +TIP, CLIP170, which shares the CAP-GLY domain 
homology with p150glued, a concentration of 200nM Taxol is sufficient to inhibit its binding to 
MT plus ends  (1999). As we did not see any effect of loss of HDAC6 on CLIP170 in our cells, 
the dampening of MT dynamics we see in cells with hyperacetylated MTs may not be sufficient 
to inhibit +TIP binding. However, it is possible that different MT +TIPs exhibit different 
sensitivities to reduction in MT dynamics. In the case of CLASP2, a member of the CLASP 
family which do not contain CAP-GLY domains and mediate binding to MTs through their TOG 
domains and additional SxIP motifs (Al-Bassam and Chang, 2011; Mimori-Kiyosue et al., 2005; 
Slep and Vale, 2007), dampened MT dynamics may contribute indirectly to decreasing CLASP2-
MT binding, instead: MT dynamics is a local regulator of Rac activity (Waterman-Storer et al., 
1999), which, in turn, regulates CLASP-MT affinity (Wittmann and Waterman-Storer, 2005). 
Additionally, a feedback loop exists between Rac1 and MTs; Rac1, a Rho GTPase involved in 
cell migration and ruffling, specifically localizes to the leading edge of migrating cells where it 
in turn could influence MT dynamics to regulate MT-+TIP interactions at the plus ends of 





The most plausible mechanism explaining our results may be that HDAC6 itself is 
directly involved in the recruitment of a subset of MT +TIPs to MT plus ends. Since HDAC6 
interacts with p150glued and other CAP-GLY containing proteins like CYLD (Kawaguchi et al., 
2003; Wickstrom et al., 2010) it may be involved in the recruitment of these proteins to MT 
+TIPs. This can explain why in HDAC6 KO cells, the loss of HDAC6 protein or activity 
inhibited p150glued localization at MT plus ends. Consistent with our model, in HDAC6 KD 
experiments, it was reported that only Arp1, a p150glued related protein and dynactin 
component, but not EB1, was slightly altered in its pattern of localization (p150glued was not 
tested in this analysis) (Zilberman et al., 2009). However, since CLIP170 was not affected, and 
EB1 binds to HDAC6, yet is present on MT plus ends in HDAC6 KO cells, there must be other 
levels of regulation determining the +TIP MT networks.  
However, we cannot as yet distinguish whether it is the specific loss of HDAC6 activity 
or the loss of its physical presence that alters the +TIP binding of p150glued and CLASPs as we 
did not investigate localization of these proteins in HDAC6 drug-inhibited cells. There is some 
precedence for altered binding of MT +TIPs in the presence of HDAC6 inhibitor as Zilberman et 
al., reported some changes in localization patterns of Arp1, another related p150glued and 
dynactin component, as well as EB1 (2009), although the proteins remained localized to MT 
+TIPs. Perhaps this can be explained by the fact that the EB1 interaction has been determined to 
occur through the N- and C-terminal domains of HDAC6 which are not involved in deacetylation 
activity. There is a possibility that the binding of p150glued, and also CLASP2, to HDAC6 is 
inhibited in the presence of HDAC6 inhibitors, as reported for the disruption of the dynein-
HDAC6 interaction in the presence of tubacin (Hideshima et al., 2005). It is interesting that the 





interacts with TOG domains or another domain in CLASPs has not yet been investigated. It will 
be thus, interesting to do a detailed analysis on +TIP binding profiles to deacetylated or 
hyperacetylated MTs with or without the presence of HDAC6 inhibitors to elucidate a 
mechanism for altered p150glued and CLASP2 binding to hyperacetylated MT plus ends. Thus, 
HDAC6 activity or the physical presence of HDAC6 on MTs may recruit specific subsets of MT 
+TIPs to the MT plus ends by direct interaction.  
In general, though, our results with localization of MT +TIPs make it hard to pinpoint a 
common mechanism of altered localizations of these proteins at MT +TIPs in cells with loss of 
HDAC6 activity.  Surprisingly, p150Glued, another CAP-Gly +TIP, is localized normally in 
TTL-null neurons (Erck et al., 2005). This is in sharp contrast to the finding that three CAP-Gly 
+TIPs (CLIP170, CLIP-115, and p150Glued) are mislocalized in TTL-null fibroblasts (Peris et 
al., 2006) Thus, there are likely different molecular mechanisms for CAP-Gly +TIP-mediated 
regulation of MT dynamics in neurons and non-neuronal cells. Moreover, while CLASP2 is 
involved in fibroblast migration (Akhmanova et al., 2001), EB1 has recently been reported to be 
involved in HDAC6-mediated directional migration of endothelial cells (Li et al., 2011a). These 
results may also indicate cell-specific differences between fibroblast and endothelial cells in 
migration. 
Hyper-acetylation of virtually all cellular MTs could also delocalize signaling pathways 
involved in MT-capture pathways. This hypothesis is supported by the finding that HDAC6-
inhibited fibroblasts did generate stabilized MT arrays, even though they failed to reorient these 
or other organelles towards the leading edge. Stabilized MT arrays can be generated by one of 
two pathways, either by the +TIPs EB1 and APC (Eng et al., 2006; Wen et al., 2004) or via the 





CLASP2 MT stabilization to the leading edge is defective in HDAC6 KO MEFs, EB1 
localization was not altered suggesting that the EB1 MT stabilization is active and functional in 
these cells. Indeed, Importantly, EB1 does not redistribute to the leading edge upon the onset of 
directional migration as reported for CLASPs which are known to be selectively localized to the 
leading edge (Lansbergen et al., 2006). Thus it is possible that these proteins are differentially 
regulated by upstream localization factors and that the localization of CLASPs but not the EB1 
family is specifically required to be at the leading edge. Of course, we did not investigate the 
localization of APC, an EB1 partner and MT stabilizer in the same pathway, in our HDAC6 KO 
MEFs. Thus, it is possible that while binding of EB1 to MTs is not regulated by signaling 
networks in cellular polarization, APC’s binding to MTs is. This is a possibility that bears further 
investigation.  
While our data point to possible mechanisms by which MT acetylation may play a role in 
cellular polarization of migrating cells, we cannot determine whether our results are attributable 
to the loss of HDAC6 activity on MT hyperacetylation as we were unable to definitively 
conclude whether the acetylation status of α-tubulin directly regulates intracellular transport in 
cell motility as both a WT and a non-acetylatable tubulin mutant equivalently rescued 
bidirectional vesicular transport. Expression of the non-acetylatable tubulin mutant has however, 
previously been shown to rescue focal adhesion turnover in HDAC6 KO MEFs (Tran and 
Bulinski, unpublished data). Although our result clearly demonstrates that a MT-based 
mechanism is responsible for inhibited cellular polarization and bidirectional intracellular 
trafficking in HDAC6 null fibroblasts, one explanation for this discrepancy can be that 
expression of tubulin in HDAC6 KO MEFs results in an increase in unmodified tubulin residues 





rescue MT-based motor transport. Therefore, determining whether modulation of the acetylation 
state of tubulin is specifically required for intracellular transport in motile cells is the focus of 
current efforts. Analysis of the acetylation-mimetic mutant, with lysine mutated to glutamine, 
which should not rescue intracellular transport unless expression results in increased unmodified 
tubulin residues along MTs or MT polymerization, will be included in this analysis.  
Alternatively, it is possible that another HDAC6 substrate or interacting partner 
modulates the effects on MT-based transport and polarization in migrating cells. HDAC6 has 
several other identified substrates (see Table 1, Chapter 1).  From the known substrates only α-
tubulin, Hsp90, and cortactin are cell motility modifiers. Though we were able to rule out Hsp90 
and cortactin, the two major HDAC6 substrates known to be involved in actin-based cell 
motility, we cannot discount the possibility of other HDAC6 substrates contributing to the 
motility defect we observe here. However, none of these other substrates are known to be direct 
cell motility modifiers and whether altering the acetylation state of these substrates contributes to 
altering directional migration remains to be determined. It is also likely that HDAC6 has 
substrates involved in the regulation of cell motility that have not yet been identified. For 
example, presence of HDAC6 in protein complexes containing the formin, mDia (Destaing et al., 
2005), GSK3β (Chen et al., 2010), PP1 (Brush et al., 2004), or SIRT2 (North et al., 2003), 
suggests that HDAC6 may deacetylate these or other substituents of these protein complexes, 
many of which are known to interact with and impact the function of MTs. The identification of 
such a factor in migrating cells that coordinates the HDAC6 and MT networks will be the subject 
of future studies.  
We find that treating WT MEFs with TSA recapitulated the behavior of HDAC6 KO 





suggesting that it is the partial or complete loss of activity of HDAC6, specifically, and not 
decreased level of HDAC6 or activity of other HDACs, that inhibits MT-dependent intracellular 
polarization and directional migration. However, there is also a possibility that, in addition to its 
deacetylase activity which we have shown is required for MT-dependent polarization in motile 
cells, HDAC6 plays a deacetylase independent or scaffolding role in the directional migration of 
fibroblasts as well as that reported for lymphoctyes (Cabrero et al., 2006). This is supported by 
the fact that in fibroblasts, the deletion of the BUZ domain caused a similar inhibition in 
directional migration as the catalytically inactive HDAC6 mutant (Gao et al., 2007). Moreover, 
the BUZ domain is implicated in linking ubiquitinated cargo to the MT motor dynein in MT-
motor dependent transport (Kawaguchi et al., 2003). Thus, it is likely that this domain has an 
important contribution in the transport of membrane vesicles and other organelles important in 
membrane turnover. 
Furthermore, as HDAC6 interacts with many proteins (see Chapter 1, Table 2) that 
impact the MT cytoskeleton, including the dynein motor (Kawaguchi et al., 2003); GSK3β 
(Chen et al., 2010), GRK2 (Lafarga et al., 2012), mDia ((Destaing et al., 2005), as well as many 
MT MAPs, including the neuronal tau (Ding et al., 2008), p150glued (Hubbert et al., 2002; 
Kawaguchi et al., 2003), Arp1 and EB1 (Zilberman et al., 2009), as well as β-tubulin (Zhang et 
al., 2003b), the scenario that HDAC6 additionally plays a deacetylase-independent role in 
fibroblast motility is likely and remains to be investigated. The direct interaction of HDAC6 with 
the MT motor dynein and MT +TIPs EB1 and p150glued (Kawaguchi et al., 2003; Zilberman et 
al., 2009) could thus explain our results with altered intracellular transport and binding of +TIPs. 
Furthermore, tubacin has been shown to disrupt the binding between dynein and MTs 





dynein loading onto MTs, or indirectly by inhibiting p150glued plus-end binding, causing the 
decreased dynein-based motility. It is possible that HDAC6 also directly interacts with and 
regulates kinesins, as has been shown for HDAC1 (Kim et al., 2010). Future studies will thus 
focus on determining whether our results are due to MT hyperacetylation caused by an inhibition 
or loss of HDAC6 activity or by a structural role of HDAC6 and will involve the use of catalytic 
inactive mutants and the BUZ domain mutant of HDAC6. We will also investigate whether +TIP 
and MT motor binding is affected by loss of a structural role of HDAC6 or its catalytic activity. 
mDia is a likely HDAC6-interacting candidate as recent studies have implicated mDia1 
in MTOC reorientation in fibroblasts and lymphocytes (Gomez et al., 2007; Yamana et al., 
2006). Furthermore, mDia1 is also shown to be involved in regulating Golgi structure formation, 
by influencing all three downstream processes, actin polymerization, myosin contractility and 
MT-based intracellular transport (Zilberman et al., 2011). GSK3β is another likely candidate to 
mediate HDAC6-dependent effects as it interacts with HDAC6 and also inhibits its deacetylase 
activity (Chen et al., 2010). Inhibition of GSK3β or its inhibition of HDAC6 activity was 
reported to enhance kinesin-1 affinity for mitochondria and increase kinesin-1-mediated 
anterograde mitochondrial transport in neurons, a result consistent with previous studies that 
showed increased affinity of the MT motor kinesin1 with Ac MTs and cargoes leading to 
enhanced polarized transport along the modified MTs (Dompierre et al., 2007; Reed et al., 2006). 
It will be interesting to see whether the polarization and intracellular transport defect in HDAC6 
KO MEFs can be rescued by the introduction of mDia or GSK3β. Interestingly, GSK3β, which 
interacts with HDAC6 (Chen et al., 2010) is involved in the regulation of both MT stabilization 
pathways involving MT +TIPs that polarize stabilized, modified MTs towards the leading edge 





involving EB1 and APC which bind to and stabilize MT plus ends (Eng et al., 2006; Wen et al., 
2004). The inhibition of GSK3β, which inhibits HDAC6 (Chen et al., 2010) is also involved in 
the regulation of CLASP2 (Akhmanova et al., 2001; Kumar et al., 2009; Lansbergen et al., 2006; 
Watanabe et al., 2009; Wittmann and Waterman-Storer, 2005). The phosphorylation of CLASP2 
by active GSK3β disrupts the localization of CLASP2 and EB1 from MT plus ends (Watanabe et 
al., 2009). However, we observed that loss of HDAC6 only affected CLASP2 localization, not 
EB1. Thus GSK3β and HDAC6 may function to coordinate these separate MT stabilization 
pathways. Furthermore, GSK3β may coordinate the actin and the MT networks required for 
efficient cell migration via regulating the interaction between CLASP2 and IQGAP1 which can 
bind both actin and MTs.  
Though we could not investigate all the substrates and HDAC6 interacting partners, we 
have ruled out most substrates involved in cell motility and investigated the obvious interacting 
proteins that regulate MT-dependent effects, namely MT motors and +TIPs. It is also puzzling 
that HDAC6 null mice are viable and do not exhibit any major defects (Zhang et al., 2008). 
However these results reflect experiments performed in homeostatic conditions. We predict that 
further studies with specific cancer and disease models will reveal a more severe defect upon the 
loss of HDAC6 in developmental, wound-healing and aberrant invasive migration in vivo. While 
there are many open questions meriting further investigation, our novel data help significantly 
advance the understanding of how HDAC6 activity modulates cell motility via MT cytoskeleton 
dependent processes thereby filling a big gap extant in this field of study. 
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